Document:

EXHIBIT 4.1

 

 

 

 

 

2020 BIO LAB NATURALS, INC.

 

STOCK OPTION AND AWARD INCENTIVE PLAN

 

    	 

    	 

    

SECTION 1: GENERAL PURPOSE OF PLAN

 

The name of this plan is
the BIO LAB NATURALS, INC. STOCK OPTION AND AWARD INCENTIVE PLAN (the "Plan"). The purpose of the Plan is to enable BIO
LAB NATURALS, INC., a Delaware corporation (the "Company"), and any Parent or any Subsidiary to obtain and retain the
services of the types of Employees, Consultants and Directors who will contribute to the Company's long range success and to provide
incentives which are linked directly to increases in share value which will inure to the benefit of all stockholders of the Company.

 

SECTION 2: DEFINITIONS

 

For purposes of the Plan, the following terms
shall be defined as set forth below:

 

"Administrator"
shall have the meaning as set forth in Section 3, hereof.

 

"Board" means
the Board of Directors of the Company.

 

"Cause" means
(i) failure by an Eligible Person to substantially perform his or her duties and obligations to the Company (other than any such
failure resulting from his or her incapacity due to physical or mental illness); (ii) engaging in misconduct or a fiduciary breach
which is or potentially is materially injurious to the Company or its stockholders; (iii) commission of a felony; (iv) the commission
of a crime against the Company which is or potentially is materially injurious to the Company; or (v) as otherwise provided in
the Stock Option Agreement or Stock Purchase Agreement. For purposes of this Plan, the existence of Cause shall be determined by
the Administrator in its sole discretion.

 

"Change in Control"
shall mean:

 

The consummation of a merger
or consolidation of the Company with or into another entity or any other corporate reorganization, if more than 50% of the combined
voting power (which voting power shall be calculated by assuming the conversion of all equity securities convertible (immediately
or at some future time) into shares entitled to vote, but not assuming the exercise of any warrant or right to subscribe to or
purchase those shares) of the continuing or Surviving Entity's securities outstanding immediately after such merger, consolidation
or other reorganization is owned, directly or indirectly, by persons who were not stockholders of the Company immediately prior
to such merger, consolidation or other reorganization; provided, however, that in making the determination of ownership by the
stockholders of the Company, immediately after the reorganization, equity securities which persons own immediately before the reorganization
as stockholders of another party to the transaction shall be disregarded; or

 

The sale, transfer or other
disposition of all or substantially all of the Company's assets.

 

A transaction shall not
constitute a Change in Control if its sole purpose is to change the state of the Company's incorporation or to create a holding
company that will be owned in substantially the same proportions by the persons who held the Company's securities immediately before
such transaction.

 

 

 

    	1 

    	 

    

"Code" means the Internal
Revenue Code of 1986, as amended from time to time.

 

"Committee" means
a committee of the Board designated by the Board to administer the Plan.

 

"Company" means
BIO LAB NATURALS, INC., a corporation organized under the laws of the State of Delaware (or any successor corporation).

 

"Consultant"
means a consultant or advisor who is a natural person or a legal entity and who provides bona fide services to the Company, a Parent
or a Subsidiary; provided such services are not in connection with the offer or sale of securities in a capital-raising transaction
and do not directly or indirectly promote or maintain a market for the Company's securities.

 

"Date of Grant"
means the date on which the Administrator adopts a resolution expressly granting a Right to a Participant or, if a different date
is set forth in such resolution as the Date of Grant, then such date as is set forth in such resolution.

 

"Director" means
a member of the Board.

 

"Disability"
means that the Optionee is unable to engage in any substantial gainful activity by reason of any medically determinable physical
or mental impairment; provided, however, for purposes of determining the term of an ISO pursuant to Section 6.6 hereof, the term
Disability shall have the meaning ascribed to it under Code Section 22(e)(3). The determination of whether an individual has a
Disability shall be determined under procedures established by the Plan Administrator.

 

"Eligible Person"
means an Employee, Consultant or Director of the Company, any Parent or any Subsidiary.

 

"Employee" shall
mean any individual who is a common-law employee (including officers) of the Company, a Parent or a Subsidiary.

 

"Exercise Price"
shall have the meaning set forth in Section 6.3 hereof.

 

"Exchange Act"
means the Securities Exchange Act of 1934, as amended.

 

"Fair Market Value"
shall mean the fair market value of a Share, determined as follows: (i) if the Stock is listed on any established stock exchange
or a national market system, including without limitation, the NASDAQ National Market, the Fair Market Value of a share of Stock
shall be the closing sales price for such stock (or the closing bid, if no sales were reported) as quoted on such system or exchange
(or the exchange with the greatest volume of trading in the Stock) on the last market trading day prior to the day of determination,
as reported in the Wall Street Journal or such other source as the Administrator deems reliable; (ii) if the Stock is quoted on
the NASDAQ System (but not on the NASDAQ National Market) or any similar system whereby the stock is regularly quoted by a recognized
securities dealer but closing sale prices are not reported, the Fair Market Value of a share of Stock shall be the mean between
the bid and asked prices for the Stock on the last market trading day prior to the day of determination, as reported in the Wall
Street Journal or such other source as the Administrator deems reliable; or (iii) in the absence of an established market for the
Stock, the Fair Market Value shall be determined in good faith by the Administrator and such determination shall be conclusive
and binding on all persons.

    	2 

    	 

    

"First Refusal Right" shall
have the meaning set forth in Section 8.7 hereof.

 

"ISO" means a
Stock Option intended to qualify as an "incentive stock option" as that term is defined in Section 422(b) of the Code.

 

"Non-Employee Director"
means a member of the Board who is not an Employee of the Company, a Parent or Subsidiary, who satisfies the requirements of such
term as defined in Rule 16b-3(b)(3)(i) promulgated by the Securities and Exchange Commission.

 

"Non-Qualified Stock
Option" means a Stock Option not described in Section 422(b) of the Code.

 

"Offeree" means
a Participant who is granted a Purchase Right pursuant to the Plan.

 

"Optionee" means
a Participant who is granted a Stock Option pursuant to the Plan.

 

"Outside Director"
means a member of the Board who is not an Employee of the Company, a Parent or Subsidiary, who satisfies the requirements of such
term as defined in Treasury Regulations (26 Code of Federal Regulation Section 1.162-27(e)(3)).

 

"Parent" means
any corporation (other than the Company) in an unbroken chain of corporations ending with the Company, if each of the corporations
other than the Company owns stock possessing 50% or more of the total combined voting power of all classes of stock in one of the
other corporations in such chain. A corporation that attains the status of a Parent on a date after the adoption of the Plan shall
be considered a Parent commencing as of such date.

 

"Participant"
means any Eligible Person selected by the Administrator, pursuant to the Administrator's authority in Section 3, to receive grants
of Rights.

 

"Plan" means
this BIO LAB NATURALS, INC. STOCK OPTION AND AWARD INCENTIVE PLAN, as the same may be amended or supplemented from time to time.

 

"Purchase Price"
shall have the meaning set forth in Section 7.3.

 

"Purchase Right"
means the right to purchase Stock granted pursuant to Section 7.

 

"Rights" means
Stock Options and Purchase Rights.

 

"Repurchase Right"
shall have the meaning set forth in Section 8.8 of the Plan.

 

"Service" shall
mean service as an Employee, Director or Consultant.

 

"Stock" means
Common Stock of the Company.

 

"Stock Option"
or "Option" means an option to purchase shares of Stock granted pursuant to Section 6.

 

"Stock Option Agreement"
shall have the meaning set forth in Section 6.1.

 

"Stock Purchase Agreement"
shall have the meaning set forth in Section 7.1.

    	3 

    	 

    

“Subsidiary"
means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company, if each of the
corporations other than the last corporation in the unbroken chain owns stock possessing 50% or more of the total combined voting
power of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Subsidiary
on a date after the adoption of the Plan shall be considered a Subsidiary commencing as of such date.

 

"Surviving Entity"
means the Company if immediately following any merger, consolidation or similar transaction, the holders of outstanding voting
securities of the Company immediately prior to the merger or consolidation own equity securities possessing more than 50% of the
voting power of the corporation existing following the merger, consolidation or similar transaction. In all other cases, the other
entity to the transaction and not the Company shall be the Surviving Entity. In making the determination of ownership by the stockholders
of an entity immediately after the merger, consolidation or similar transaction, equity securities which the stockholders owned
immediately before the merger, consolidation or similar transaction as stockholders of another party to the transaction shall be
disregarded. Further, outstanding voting securities of an entity shall be calculated by assuming the conversion of all equity securities
convertible (immediately or at some future time) into shares entitled to vote.

 

"Ten Percent Stockholder"
means a person who on the Date of Grant owns, either directly or through attribution as provided in Section 424 of the Code, Stock
constituting more than 10% of the total combined voting power of all classes of stock of his or her employer corporation or of
any Parent or Subsidiary.

 

SECTION 3: ADMINISTRATION

 

3.1 Administrator. The
Plan shall be administered by either (i) the Board, or (ii) a Committee appointed by the Board (the group that administers the
Plan is referred to as the "Administrator").

 

3.2 Powers in General.
The Administrator shall have the power and authority to grant to Eligible Persons, pursuant to the terms of the Plan, (i) Stock
Options, (ii) Purchase Rights or (iii) any combination of the foregoing.

 

3.3 Specific Powers. In
particular, the Administrator shall have the authority: (i) to construe and interpret the Plan and apply its provisions; (ii) to
promulgate, amend and rescind rules and regulations relating to the administration of the Plan; (iii) to authorize any person to
execute, on behalf of the Company, any instrument required to carry out the purposes of the Plan; (iv) to determine when Rights
are to be granted under the Plan; (v) from time to time to select, subject to the limitations set forth in this Plan, those Eligible
Persons to whom Rights shall be granted; (vi) to determine the number of shares of Stock to be made subject to each Right; (vii)
to determine whether each Stock Option is to be an ISO or a Non-Qualified Stock Option; (viii) to prescribe the terms and conditions
of each Stock Option and Purchase Right, including, without limitation, the Purchase Price and medium of payment, vesting provisions
and repurchase provisions, and to specify the provisions of the Stock Option Agreement or Stock Purchase Agreement relating to
such grant or sale; (ix) to amend any outstanding Rights for the purpose of modifying the time or manner of vesting, the Purchase
Price or Exercise Price, as the case may be, subject to applicable legal restrictions and to the consent of the other party to
such agreement; (x) to determine the duration and purpose of leaves of absences which may be granted to a Participant without constituting
termination of their employment for purposes of the Plan; (xi) to make decisions with respect to outstanding Stock Options that
may become necessary upon a

    	4 

    	 

    

change in corporate control or an event that
triggers anti-dilution adjustments; and (xii) to make any and all other determinations which it determines to be necessary or advisable
for administration of the Plan.

 

3.4 Decisions Final. All
decisions made by the Administrator pursuant to the provisions of the Plan shall be final and binding on the Company and the Participants.

 

3.5 The Committee. The
Board may, in its sole and absolute discretion, from time to time, and at any period of time during which the Company's Stock is
registered pursuant to Section 12 of the Exchange Act, delegate any or all of its duties and authority with respect to the Plan
to the Committee whose members are to be appointed by and to serve at the pleasure of the Board. From time to time, the Board may
increase or decrease the size of the Committee, add additional members to, remove members (with or without cause) from, appoint
new members in substitution therefor, and fill vacancies, however caused, in the Committee. The Committee shall act pursuant to
a vote of the majority of its members or, in the case of a committee comprised of only two members, the unanimous consent of its
members, whether present or not, or by the unanimous written consent of the majority of its members and minutes shall be kept of
all of its meetings and copies thereof shall be provided to the Board. Subject to the limitations prescribed by the Plan and the
Board, the Committee may establish and follow such rules and regulations for the conduct of its business as it may determine to
be advisable. During any period of time during which the Company's Stock is registered pursuant to Section 12 of the Exchange Act,
all members of the Committee shall be Non-Employee Directors and Outside Directors.

 

3.6 Indemnification. In
addition to such other rights of indemnification as they may have as Directors or members of the Committee, and to the extent allowed
by applicable law, the Administrator and each of the Administrator's consultants shall be indemnified by the Company against the
reasonable expenses, including attorney's fees, actually incurred in connection with any action, suit or proceeding or in connection
with any appeal therein, to which the Administrator or any of its consultants may be party by reason of any action taken or failure
to act under or in connection with the Plan or any option granted under the Plan, and against all amounts paid by the Administrator
or any of its consultants in settlement thereof (provided that the settlement has been approved by the Company, which approval
shall not be unreasonably withheld) or paid by the Administrator or any of its consultants in satisfaction of a judgment in any
such action, suit or proceeding, except in relation to matters as to which it shall be adjudged in such action, suit or proceeding
that such Administrator or any of its consultants did not act in good faith and in a manner which such person reasonably believed
to be in the best interests of the Company, or was grossly negligent, and in the case of a criminal proceeding, had no reason to
believe that the conduct complained of was unlawful; provided, however, that within 60 days after institution of any such action,
suit or proceeding, such Administrator or any of its consultants shall, in writing, offer the Company the opportunity at its own
expense to handle and defend such action, suit or proceeding.

 

SECTION 4: STOCK SUBJECT TO THE PLAN

 

4.1 Stock Subject to the
Plan. Subject to adjustment as provided in Section 9, Two Million (2,000,000) shares of Common Stock shall be reserved and available
for issuance under the Plan. Stock reserved hereunder may consist, in whole or in part, of authorized and unissued shares or treasury
shares.

    	5 

    	 

    

4.2 Basic Limitation. The
number of shares that are subject to Rights under the Plan shall not exceed the number of shares that then remain available for
issuance under the Plan. The Company, during the term of the Plan, shall at all times reserve and keep available a sufficient number
of shares to satisfy the requirements of the Plan.

 

4.3 Additional Shares.
In the event that any outstanding Option or other right for any reason expires or is canceled or otherwise terminated, the shares
allocable to the unexercised portion of such Option or other right shall again be available for the purposes of the Plan. In the
event that shares issued under the Plan are reacquired by the Company pursuant to the terms of any forfeiture provision, right
of repurchase or right of first refusal, such shares shall again be available for the purposes of the Plan.

 

SECTION 5: ELIGIBILITY

 

Eligible Persons who are
selected by the Administrator shall be eligible to be granted Rights hereunder subject to limitations set forth in this Plan; provided,
however, that only Employees shall be eligible to be granted ISOs hereunder.

 

SECTION 6: TERMS AND CONDITIONS OF OPTIONS.

 

6.1 Stock Option Agreement.
Each grant of an Option under the Plan shall be evidenced by a Stock Option Agreement between the Optionee and the Company. Such
Option shall be subject to all applicable terms and conditions of the Plan and may be subject to any other terms and conditions
which are not inconsistent with the Plan and which the Administrator deems appropriate for inclusion in a Stock Option Agreement.
The provisions of the various Stock Option Agreements entered into under the Plan need not be identical.

 

6.2 Number of Shares. Each
Stock Option Agreement shall specify the number of shares of Stock that are subject to the Option and shall provide for the adjustment
of such number in accordance with Section 9, hereof. The Stock Option Agreement shall also specify whether the Option is an ISO
or a Non-Qualified Stock Option.

 

6.3 Exercise Price.

 

6.3.1 In General.
Each Stock Option Agreement shall state the price at which shares subject to the Stock Option may be purchased (the "Exercise
Price"), which shall, with respect to Incentive Stock Options, be not less than 100% of the Fair Market Value of the Stock
on the Date of Grant. In the case of Non-Qualified Stock Options, the Exercise Price shall be determined in the sole discretion
of the Administrator.

 

6.3.2 Payment.
The Exercise Price shall be payable in a form described in Section 8 hereof.

 

6.4 Withholding Taxes.
As a condition to the exercise of an Option, the Optionee shall make such arrangements as the Board may require for the satisfaction
of any federal, state, local or foreign withholding tax obligations that may arise in connection with such exercise or with the
disposition of shares acquired by exercising an Option.

 

6.5 Exercisability. Each
Stock Option Agreement shall specify the date when all or any installment of the Option becomes exercisable. In the case of an
Optionee who is not an officer of the Company, a Director or a Consultant, an Option shall become exercisable at a rate of no more

    	6 

    	 

    

than 25% per year over a four-year period commencing
on January 1 following the Date of Grant and 25% each year thereafter on January 1. Subject to the preceding sentence, the exercise
provisions of any Stock Option Agreement shall be determined by the Administrator, in its sole discretion.

 

6.6 Term. The Stock Option
Agreement shall specify the term of the Option. No Option shall be exercised after the expiration of ten years after the date the
Option is granted. Unless otherwise provided in the Stock Option Agreement, no Option may be exercised (i) three months after the
date the Optionee's Service with the Company, its Parent or its Subsidiaries terminates if such termination is for any reason other
than death, Disability or Cause, (ii) one year after the date the Optionee's Service with the Company, its Parent or its subsidiaries
terminates if such termination is a result of death or Disability, and (iii) if the Optionee's Service with the Company, its Parent,
or its Subsidiaries terminates for Cause, all outstanding Options granted to such Optionee shall expire as of the commencement
of business on the date of such termination. The Administrator may, in its sole discretion, waive the accelerated expiration provided
for in (i) or (ii). Outstanding Options that are not exercisable at the time of termination of employment for any reason shall
expire at the close of business on the date of such termination.

 

6.7 Leaves of Absence.
For purposes of Section 6.6 above, to the extent required by applicable law, Service shall be deemed to continue while the Optionee
is on a bona fide leave of absence. To the extent applicable law does not require such a leave to be deemed to continue while the
Optionee is on a bona fide leave of absence, such leave shall be deemed to continue if, and only if, expressly provided in writing
by the Administrator or a duly authorized officer of the Company, Parent, or Subsidiary for whom Optionee provides his or her services.

 

6.8 Modification, Extension
and Assumption of Options. Within the limitations of the Plan, the Administrator may modify, extend or assume outstanding Options
(whether granted by the Company or another issuer) or may accept the cancellation of outstanding Options (whether granted by the
Company or another issuer) in return for the grant of new Options for the same or a different number of shares and at the same
or a different Exercise Price. Without limiting the foregoing, the Administrator may amend a previously granted Option to fully
accelerate the exercise schedule of such Option and provide that upon the exercise of such Option, the Optionee shall receive shares
of Restricted Stock that are subject to repurchase by the Company at the Exercise Price paid for the Option in accordance with
Section 8.8.1 with such Company's right to repurchase at such price lapsing at the same rate as the exercise provisions set forth
in Optionee's Stock Option Agreement. The foregoing notwithstanding, no modification of an Option shall, without the consent of
the Optionee, impair the Optionee's rights or increase the Optionee's obligations under such Option. However, a termination of
the Option in which the Optionee receives a cash payment equal to the difference between the Fair Market Value and the Exercise
Price for all shares subject to exercise under any outstanding Option shall not be deemed to impair any rights of the Optionee
or increase the Optionee's obligations under such Option.

 

SECTION 7: TERMS AND CONDITIONS OF AWARDS OR
SALES

 

7.1 Stock Purchase Agreement.
Each award or sale of shares under the Plan (other than upon exercise of an Option) shall be evidenced by a Stock Purchase Agreement
between the Purchaser and the Company. Such award or sale shall be subject to all applicable terms and conditions of the Plan and
may be subject to any other terms and conditions which are not inconsistent with the Plan and which the Board deems appropriate
for inclusion in a Stock Purchase Agreement. The provisions of the various Stock Purchase Agreements entered into under the Plan
need not be identical.

    	7 

    	 

    

 

7.2 Duration of Offers.
Unless otherwise provided in the Stock Purchase Agreement, any right to acquire shares under the Plan (other than an Option) shall
automatically expire if not exercised by the Purchaser within 15 days after the grant of such right was communicated to the Purchaser
by the Company.

 

7.3 Purchase Price.

 

7.3.1 In General.
Each Stock Purchase Agreement shall state the price at which the Stock subject to such Stock Purchase Agreement may be purchased
(the "Purchase Price"), which, with respect to Stock Purchase Rights, shall be determined in the sole discretion of the
Administrator.

 

7.3.2 Payment
of Purchase Price. The Purchase Price shall be payable in a form described in Section 8.

 

7.4 Withholding Taxes.
As a condition to the purchase of shares, the Purchaser shall make such arrangements as the Board may require for the satisfaction
of any federal, state, local or foreign withholding tax obligations that may arise in connection with such purchase.

 

SECTION 8: PAYMENT; RESTRICTIONS

 

8.1 General Rule. The entire
Purchase Price or Exercise Price of shares issued under the Plan shall be payable in full by, as applicable, cash or certified
check for an amount equal to the aggregate Purchase Price or Exercise Price for the number of shares being purchased, or in the
discretion of the Administrator, upon such terms as the Administrator shall approve, (i) in the case of an Option and provided
the Company's stock is publicly traded, by a copy of instructions to a broker directing such broker to sell the Stock for which
such Option is exercised, and to remit to the Company the aggregate Exercise Price of such Options (a "cashless exercise"),
(ii) in the case of an Option or a sale of Stock, by paying all or a portion of the Exercise Price or Purchase Price for the number
of shares being purchased by tendering Stock owned by the Optionee, duly endorsed for transfer to the Company, with a Fair Market
Value on the date of delivery equal to the aggregate Purchase Price of the Stock with respect to which such Option or portion thereof
is thereby exercised or Stock acquired (a "stock-for-stock exercise") or (iii) by a stock-for-stock exercise by means
of attestation whereby the Optionee identifies for delivery specific shares of Stock already owned by Optionee and receives a number
of shares of Stock equal to the difference between the Option shares thereby exercised and the identified attestation shares of
Stock (an "attestation exercise").

 

8.2 Withholding Payment.
The Purchase Price or Exercise Price shall include payment of the amount of all federal, state, local or other income, excise or
employment taxes subject to withholding (if any) by the Company or any parent or subsidiary corporation as a result of the exercise
of a Stock Option. The Optionee may pay all or a portion of the tax withholding by cash or check payable to the Company, or, at
the discretion of the Administrator, upon such terms as the Administrator shall approve, by (i) cashless exercise or attestation
exercise; (ii) stock-for-stock exercise; (iii) in the case of an Option, by paying all or a portion of the tax withholding for
the number of shares being purchased by withholding shares from any transfer or payment to the Optionee ("Stock withholding");
or (iv) a combination of one or more of the foregoing payment methods. Any shares issued pursuant to the exercise of an Option
and transferred by the Optionee to the Company for the purpose of satisfying any withholding obligation shall not again be available
for purposes of the Plan. The Fair Market Value of the number of shares subject to

    	8 

    	 

    

Stock withholding shall not exceed an amount
equal to the applicable minimum required tax withholding rates.

 

8.3 Services Rendered.
At the discretion of the Administrator, shares may be awarded under the Plan in consideration of services rendered to the Company,
a Parent or a Subsidiary prior to the award.

 

8.4 Promissory Note. To
the extent that a Stock Option Agreement or Stock Purchase Agreement so provides, in the discretion of the Administrator, upon
such terms as the Administrator shall approve, all or a portion of the Exercise Price or Purchase Price (as the case may be) of
shares issued under the Plan may be paid with a full-recourse promissory note. However, in the event there is a stated par value
of the shares and applicable law requires, the par value of the shares, if newly issued, shall be paid in cash or cash equivalents.
The shares shall be pledged as security for payment of the principal amount of the promissory note and interest thereon, and held
in the possession of the Company until said amounts are repaid in full. The interest rate payable under the terms of the promissory
note shall not be less than the minimum rate (if any) required to avoid the imputation of additional interest under the Code. Subject
to the foregoing, the Administrator (at its sole discretion) shall specify the term, interest rate, amortization requirements (if
any) and other provisions of such note. Unless the Administrator determines otherwise, shares of Stock having a Fair Market Value
at least equal to the principal amount of the loan shall be pledged by the holder to the Company as security for payment of the
unpaid balance of the loan and such pledge shall be evidenced by a pledge agreement, the terms of which shall be determined by
the Administrator, in its discretion; provided, however, that each loan shall comply with all applicable laws, regulations and
rules of the Board of Governors of the Federal Reserve System and any other governmental agency having jurisdiction.

 

8.5 Exercise/Pledge. To
the extent that a Stock Option Agreement or Stock Purchase Agreement so allows and if Stock is publicly traded, in the discretion
of the Administrator, upon such terms as the Administrator shall approve, payment may be made all or in part by the delivery (on
a form prescribed by the Administrator) of an irrevocable direction to pledge shares to a securities broker or lender approved
by the Company, as security for a loan, and to deliver all or part of the loan proceeds to the Company in payment of all or part
of the Exercise Price and any withholding taxes.

 

8.6 Written Notice. The
purchaser shall deliver a written notice to the Administrator requesting that the Company direct the transfer agent to issue to
the purchaser (or to his designee) a certificate for the number of shares of Common Stock being exercised or purchased or, in the
case of a cashless exercise or share withholding exercise, for any shares that were not sold in the cashless exercise or withheld.

 

8.7 First Refusal Right.
Each Stock Option Agreement and Stock Purchase Agreement may provide that the Company shall have the right of first refusal (the
"First Refusal Right"), exercisable in connection with any proposed sale, hypothecation or other disposition of the Stock
purchased by the Optionee or Offeree pursuant to a Stock Option Agreement or Stock Purchase Agreement; and in the event the holder
of such Stock desires to accept a bona fide third-party offer for any or all of such Stock, the Stock shall first be offered to
the Company upon the same terms and conditions as are set forth in the bona fide offer.

 

8.8 Repurchase Rights.
Following a termination of the Participant's Service, the Company may repurchase the Participant's Rights as provided in this Section
8.8 (the "Repurchase Right").

    	9 

    	 

    

8.8.1 Repurchase
Price. Following a termination of the Participant's Service the Repurchase Right shall be exercisable at a price equal to (i) the
Fair Market Value of vested Stock or, in the case of exercisable options, the Fair Market Value of the Stock underlying such unexercised
options less the Exercise Price, or (ii) the Purchase Price or Exercise Price, as the case may be, of unvested Stock; provided,
however, the right to repurchase unvested stock as described in Section 8.8.1(ii) shall lapse at a rate of at least 33.33% per
year over three years from the date the Right is granted.

 

8.8.2 Exercise
of Repurchase Right. A Repurchase Right may be exercised only within 90 days after the termination of the Participant's Service
(or in the case of Stock issued upon exercise of an Option or after the date of termination or the purchase of Stock under a Stock
Purchase Agreement after the date of termination, within 90 days after the date of the exercise or Stock purchase, whichever is
applicable) for cash or for cancellation of indebtedness incurred in purchasing the shares.

 

8.9 Termination of Repurchase
and First Refusal Rights. Each Stock Option Agreement and Stock Purchase Agreement shall provide that the Repurchase Rights and
First Refusal Rights shall have no effect with respect to, or shall lapse and cease to have effect when the issuer's securities
become publicly traded or a determination is made by counsel for the Company that such Repurchase Rights and First Refusal Rights
are not permitted under applicable federal or state securities laws.

 

8.10 No Transferability.
Except as provided herein, a Participant may not assign, sell or transfer Rights, in whole or in part, other than by testament
or by operation of the laws of descent and distribution.

 

8.10.1 Permitted
Transfer of Non-Qualified Option. The Administrator, in its sole discretion may permit the transfer of a Non-Qualified Option (but
not an ISO or Stock Purchase Right) as follows: (i) by gift to a member of the Participant's immediate family, or (ii) by transfer
by instrument to a trust providing that the Option is to be passed to beneficiaries upon death of the Settlor (either or both (i)
or (ii) referred to as a "Permitted Transferee"). For purposes of this Section 8.10.1, "immediate family" shall
mean the Optionee's spouse (including a former spouse subject to terms of a domestic relations order); child, stepchild, grandchild,
child-in-law; parent, stepparent, grandparent, parent-in-law; sibling and sibling-in-law, and shall include adoptive relationships.

 

8.10.2 Conditions
of Permitted Transfer. A transfer permitted under this Section 8.10 hereof may be made only upon written notice to and approval
thereof by Administrator. A Permitted Transferee may not further assign, sell or transfer the transferred Option, in whole or in
part, other than by testament or by operation of the laws of descent and distribution. A Permitted Transferee shall agree in writing
to be bound by the provisions of this Plan, which a copy of said agreement shall be provided to the Administrator for approval
prior to the transfer.

 

SECTION 9: ADJUSTMENTS; MARKET STAND-OFF

 

9.1 Effect of Certain Changes.

 

9.1.1 Stock Dividends,
Splits, Etc. If there is any change in the number of outstanding shares of Stock by reason of a stock split, reverse stock split,
stock dividend, recapitalization, combination or reclassification, then (i) the number of shares of Stock

    	10 

    	 

    

available for Rights, (ii) the number
of shares of Stock covered by outstanding Rights, and (iii) the Exercise Price or Purchase Price of any Stock Option or Purchase
Right, in effect prior to such change, shall be proportionately adjusted by the Administrator to reflect any increase or decrease
in the number of issued shares of Stock; provided, however, that any fractional shares resulting from the adjustment shall be eliminated.

 

9.1.2 Liquidation,
Dissolution, Merger or Consolidation. In the event of a dissolution or liquidation of the Company, or any corporate separation
or division, including, but not limited to, a split-up, a split-off or a spin-off, or a sale of substantially all of the assets
of the Company; a merger or consolidation in which the Company is not the Surviving Entity; or a reverse merger in which the Company
is the Surviving Entity, but the shares of Company stock outstanding immediately preceding the merger are converted by virtue of
the merger into other property, whether in the form of securities, cash or otherwise, then, the Company, to the extent permitted
by applicable law, but otherwise in its sole discretion may provide for: (i) the continuation of outstanding Rights by the Company
(if the Company is the Surviving Entity); (ii) the assumption of the Plan and such outstanding Rights by the Surviving Entity or
its parent; (iii) the substitution by the Surviving Entity or its parent of Rights with substantially the same terms for such outstanding
Rights; or (iv) the cancellation of such outstanding Rights without payment of any consideration, provided that if such Rights
would be canceled in accordance with the foregoing, the Participant shall have the right, exercisable during the later of the ten-day
period ending on the fifth day prior to such merger or consolidation or ten days after the Administrator provides the Rights holder
a notice of cancellation, to exercise such Rights in whole or in part without regard to any installment exercise provisions in
the Rights agreement.

 

9.1.3 Par Value
Changes. In the event of a change in the Stock of the Company as presently constituted which is limited to a change of all of its
authorized shares with par value, into the same number of shares without par value, or a change in the par value, the shares resulting
from any such change shall be "Stock" within the meaning of the Plan.

 

9.2 Decision of Administrator
Final. To the extent that the foregoing adjustments relate to stock or securities of the Company, such adjustments shall be made
by the Administrator, whose determination in that respect shall be final, binding and conclusive; provided, however, that each
ISO granted pursuant to the Plan shall not be adjusted in a manner that causes such Stock Option to fail to continue to qualify
as an ISO without the prior consent of the Optionee thereof.

 

9.3 No Other Rights. Except
as hereinbefore expressly provided in this Section 9, no Participant shall have any rights by reason of any subdivision or consolidation
of shares of Company stock or the payment of any dividend or any other increase or decrease in the number of shares of Company
stock of any class or by reason of any of the events described in Section 9.1, above, or any other issue by the Company of shares
of stock of any class, or securities convertible into shares of stock of any class; and, except as provided in this Section 9,
none of the foregoing events shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price
of shares of Stock subject to Rights. The grant of a Right pursuant to the Plan shall not affect in any way the right or power
of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or business structures or to merge
or to consolidate or to dissolve, liquidate or sell, or transfer all or part of its business or assets.

 

    	11 

    	 

    

9.4 Market Stand-Off. Each
Stock Option Agreement and Stock Purchase Agreement shall provide that, in connection with any underwritten public offering by
the Company of its equity securities pursuant to an effective registration statement filed under the Securities Act of 1933, as
amended, including the Company's initial public offering, the Participant shall agree not to sell, make any short sale of, loan,
hypothecate, pledge, grant any option for the repurchase of, or otherwise dispose or transfer for value or otherwise agree to engage
in any of the foregoing transactions with respect to any Stock without the prior written consent of the Company or its underwriters,
for such period of time from and after the effective date of such registration statement as may be requested by the Company or
such underwriters (the "Market Stand-Off").

 

SECTION 10: AMENDMENT AND TERMINATION

 

The Board may amend, suspend
or terminate the Plan at any time and for any reason. At the time of such amendment, the Board shall determine, upon advice from
counsel, whether such amendment will be contingent on stockholder approval.

 

SECTION 11: GENERAL PROVISIONS

 

11.1 General Restrictions.

 

11.1.1 No View
to Distribute. The Administrator may require each person acquiring shares of Stock pursuant to the Plan to represent to and agree
with the Company in writing that such person is acquiring the shares without a view towards distribution thereof. The certificates
for such shares may include any legend that the Administrator deems appropriate to reflect any restrictions on transfer.

 

11.1.2 Legends.
All certificates for shares of Stock delivered under the Plan shall be subject to such stop transfer orders and other restrictions
as the Administrator may deem advisable under the rules, regulations and other requirements of the Securities and Exchange Commission,
any stock exchange upon which the Stock is then listed and any applicable federal or state securities laws, and the Administrator
may cause a legend or legends to be put on any such certificates to make appropriate reference to such restrictions.

 

11.1.3 No Rights
as Stockholder. Except as specifically provided in this Plan, a Participant or a transferee of a Right shall have no rights as
a stockholder with respect to any shares covered by the Rights until the date of the issuance of a Stock certificate to him or
her for such shares, and no adjustment shall be made for dividends (ordinary or extraordinary, whether in cash, securities or other
property) or distributions of other rights for which the record date is prior to the date such Stock certificate is issued, except
as provided in Section 9.1, hereof.

 

11.2 Other Compensation
Arrangements. Nothing contained in this Plan shall prevent the Board from adopting other or additional compensation arrangements,
subject to stockholder approval if such approval is required; and such arrangements may be either generally applicable or applicable
only in specific cases.

 

11.3 Disqualifying Dispositions.
Any Participant who shall make a "disposition" (as defined in Section 424 of the Code) of all or any portion of an ISO
within two years from the date of grant of such ISO or within one year after the issuance of the shares of Stock acquired upon

    	12 

    	 

    

exercise of such ISO shall be required to immediately
advise the Company in writing as to the occurrence of the sale and the price realized upon the sale of such shares of Stock.

 

11.4 Regulatory Matters.
Each Stock Option Agreement and Stock Purchase Agreement shall provide that no shares shall be purchased or sold thereunder unless
and until (i) any then applicable requirements of state or federal laws and regulatory agencies shall have been fully complied
with to the satisfaction of the Company and its counsel and (ii) if required to do so by the Company, the Optionee or Offeree shall
have executed and delivered to the Company a letter of investment intent in such form and containing such provisions as the Board
or Committee may require.

 

11.5 Recapitalizations.
Each Stock Option Agreement and Stock Purchase Agreement shall contain provisions required to reflect the provisions of Section
9.

 

11.6 Delivery. Upon exercise
of a Right granted under this Plan, the Company shall issue Stock or pay any amounts due within a reasonable period of time thereafter.
Subject to any statutory obligations the Company may otherwise have, for purposes of this Plan, thirty days shall be considered
a reasonable period of time.

 

11.7 Other Provisions.
The Stock Option Agreements and Stock Purchase Agreements authorized under the Plan may contain such other provisions not inconsistent
with this Plan, including, without limitation, restrictions upon the exercise of the Rights, as the Administrator may deem advisable.

 

SECTION 12: INFORMATION TO PARTICIPANTS

 

To the extent necessary
to comply with Delaware law, the Company each year shall furnish to Participants its balance sheet and income statement unless
such Participants are limited to key Employees whose duties with the Company assure them access to equivalent information.

 

SECTION 13: STOCKHOLDERS AGREEMENT

 

As a condition to the transfer
of Stock pursuant to a Right granted under this Plan, the Administrator, in its sole and absolute discretion, may require the Participant
to execute and become a party to any agreement by and among the Company and any of its stockholders which exists on or after the
Date of Grant (the "Stockholders Agreement"). If the Participant becomes a party to a Stockholders Agreement, in addition
to the terms of this Plan and the Stock Option Agreement or Stock Purchase Agreement (whichever is applicable) pursuant to which
the Stock is transferred, the terms and conditions of the Stockholders Agreement shall govern Participant's rights in and to the
Stock; and if there is any conflict between the provisions of the Stockholders Agreement and this Plan or any conflict between
the provisions of the Stockholders Agreement and the Stock Option Agreement or Stock Purchase Agreement (whichever is applicable)
pursuant to which the Stock is transferred, the provisions of the Stockholders Agreement shall be controlling. Notwithstanding
anything to the contrary in this Section 13, if the Stockholders Agreement contains any provisions which would violate the Delaware
Corporations Code if applied to the Participant, the terms of this Plan and the Stock Option Agreement or Stock Purchase Agreement
(whichever is applicable) pursuant to which the Stock is transferred shall govern the Participant's rights with respect to such
provisions.

 

    	13 

    	 

    

SECTION 14: EFFECTIVE DATE OF PLAN

 

The effective date of
this Plan is January 15, 2020. The adoption of the Plan is subject to approval by the Company's stockholders, which approval
must be obtained within 12 months from the date the Plan is adopted by the Board. In the event that the stockholders fail to
approve the Plan within 12 months after its adoption by the Board, any grants of Options or sales or awards of shares that
have already occurred shall be rescinded, and no additional grants, sales or awards shall be made thereafter under the
Plan.

 

SECTION 15: TERM OF PLAN

 

The Plan shall
terminate automatically on January 15, 2030, but no later than the tenth (10th) anniversary of the effective date. No Right
shall be granted pursuant to the Plan after such date, but Rights theretofore granted may extend beyond that date. The Plan
may be terminated on any earlier date pursuant to Section 10 hereof.

 

SECTION 16: EXECUTION

 

To record the adoption
of the Plan by the Board, the Company has caused its authorized officer to execute the same as of January 15, 2020.

 

 

 

BIO LAB NATURALS, INC.

 

 

By: /s/ W. Edward Nichols

__________________________________________

W. Edward Nichols, Chief Executive Officer

    	14 

    	 

    

 

STOCK OPTION AGREEMENT

BIO LAB NATURALS, INC.

STOCK OPTION AND INCENTIVE AWARD PLAN

Notice Of Stock Option Grant

 

You have been granted the following option
to purchase Common Stock of BIO LAB NATURALS, INC. (the "Company"):

 

Name of Optionee:

 

Total Number of Shares Granted:

 

Type of Option:

 

Exercise Price Per Share:

 

Date of Grant:

 

Vesting Commencement Date:

 

Vesting Schedule:

 

Expiration Date:

 

By your signature and the signature of the
Company's authorized representative below, you and the Company agree that this option is granted under and governed by the terms
and conditions of the BIO LAB NATURALS, INC. STOCK OPTION AND AWARD INCENTIVE PLAN and the STOCK OPTION AGREEMENT, both of which
are attached hereto and are incorporated herein by reference. Optionee hereby represents that both the option and any shares acquired
upon exercise of the option have been or will be acquired for investment for his own account and not with a view to or for sale
in connection with any distribution or resale of the security.

 

	Optionee:	BIO LAB NATURALS, INC.
	By:	By:
	Name:	W. EDWARD NICHOLS
	 	CEO

 

 

 

 

 

    	15 

    	 

    

ANNEX I

 

 

THE OPTION GRANTED PURSUANT TO THIS AGREEMENT
AND THE SHARES ISSUABLE UPON THE EXERCISE THEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY
NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL,
SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION IS NOT REQUIRED.

 

 

BIO LAB NATURALS, INC.

STOCK OPTION AND AWARD INCENTIVE PLAN:

STOCK OPTION AGREEMENT

 

SECTION 1: GRANT OF OPTION

 

1.1 Option. On the terms
and conditions set forth in the notice of stock option grant to which this agreement (the "Agreement") is attached (the
"Notice of Stock Option Grant") and this agreement, the Company grants to the individual named in the Notice of Stock
Option Grant (the "Optionee") the option to purchase at the exercise price specified in the Notice of Stock Option Grant
(the "Exercise Price") the number of Shares set forth in the Notice of Stock Option Grant. This option is intended to
be either an ISO or a Non-Qualified Stock Option, as provided in the Notice of Stock Option Grant.

 

1.2 Stock Plan and Defined
Terms. This option is granted pursuant to and subject to the terms of the BIO LAB NATURALS, INC. STOCK OPTION AND AWARD INCENTIVE
PLAN, as in effect on the date specified in the Notice of Stock Option Grant (which date shall be the later of (i) the date on
which the Board resolved to grant this option, or (ii) the first day of the Optionee's Service) and as amended from time to time
(the "Plan"), a copy of which is attached hereto and which the Optionee acknowledges having received. Capitalized terms
not otherwise defined in this Agreement have the definitions ascribed to them in the Plan.

 

SECTION 2: RIGHT TO EXERCISE

 

2.1 Exercisability. Subject
to Sections 2.2 and 2.3 below and the other conditions set forth in this Agreement, all or part of this option may be exercised
prior to its expiration at the time or times set forth in the Notice of Stock Option Grant. Shares purchased by exercising this
option may be subject to the Right of Repurchase under Section 7. In addition, all of the remaining unexercised options shall become
vested and fully exercisable if (i) a Change in Control occurs before the Optionee's Service terminates, and (ii) the option is
not assumed or an equivalent option is not substituted by the successor entity that employs the Optionee immediately after the
Change in Control or by its parent or subsidiary.

 

2.2 Limitation. If this
option is designated as an ISO in the Notice of Stock Option Grant, then to the extent (and only to the extent) the Optionee's
right to exercise this option causes this option (in whole or in part) to not be treated as an ISO by reason of the $100,000 annual
limitation under Section 422(d) of the Code, such options shall be treated as Non-Qualified Stock

Options, but shall be exercisable by their
terms. The determination of options to be treated as Non-Qualified Stock Options shall be made by taking options into account in
the order in which they are granted. If the terms of this option cause the $100,000 annual limitation under Section

    	16 

    	 

    

422(d) of the Code to be exceeded, a pro rata
portion of each exercise shall be treated as the exercise of a Non-Qualified Stock Option.

 

2.3 Stockholder Approval.
Any other provision of this Agreement notwithstanding, no portion of this option shall be exercisable at any time prior to the
approval of the Plan by the Company's stockholders.

 

SECTION 3: NO TRANSFER OR ASSIGNMENT OF OPTION

 

Except as provided herein,
an Optionee may not assign, sell or transfer the option, in whole or in part, other than by testament or by operation of the laws
of descent and distribution. The Administrator, in its sole discretion may permit the transfer of a Non-Qualified Option (but not
an ISO) as follows: (i) by gift to a member of the Participant's immediate family, or (ii) by transfer by instrument to a trust
providing that the Option is to be passed to beneficiaries upon death of the Settlor (either or both (i) or (ii) referred to as
a "Permitted Transferee"). For purposes of this Section 3, "immediate family" shall mean the Optionee's spouse
(including a former spouse subject to terms of a domestic relations order); child, stepchild, grandchild, child-in-law; parent,
stepparent, grandparent, parent-in-law; sibling and sibling-in-law, and shall include adoptive relationships. A transfer permitted
under this Section 3 hereof may be made only upon written notice to and approval thereof by Administrator. A Permitted Transferee
may not further assign, sell or transfer the transferred option, in whole or in part, other than by testament or by operation of
the laws of descent and distribution. A Permitted Transferee shall agree in writing to be bound by the provisions of this Plan,
which agreement shall be submitted to and approved by the Administrator before the transfer.

 

SECTION 4: EXERCISE PROCEDURES

 

4.1 Notice of Exercise.
The Optionee or the Optionee's representative may exercise this option by delivering a written notice in the form of Exhibit A
attached hereto ("Notice of Exercise") to the Company in the manner specified pursuant to Section 14.4 hereof. Such Notice
of Exercise shall specify the election to exercise this option, the number of Shares for which it is being exercised and the form
of payment, which must comply with Section 5. The Notice of Exercise shall be signed by the person who is entitled to exercise
this option. In the event that this option is to be exercised by the Optionee's representative, the notice shall be accompanied
by proof (satisfactory to the Company) of the representative's right to exercise this option.

 

4.2 Issuance of Shares.
After receiving a proper Notice of Exercise, the Company shall cause to be issued a certificate or certificates for the Shares
as to which this option has been exercised, registered in the name of the person exercising this option (or in the names of such
person and his or her spouse as community property or as joint tenants with right of survivorship). The Company shall cause such
certificate or certificates to be deposited in escrow or delivered to or upon the order of the person exercising this option.

 

4.3 Withholding Taxes.
In the event that the Company determines that it is required to withhold any tax as a result of the exercise of this option, the
Optionee, as a condition to the exercise of this option, shall make arrangements satisfactory to the Company to enable it to satisfy
all withholding requirements. The Optionee shall also make arrangements satisfactory to the Company to enable it to satisfy any
withholding requirements that may arise in connection with the vesting or disposition of Shares purchased by exercising this option,
and shall provide to the Company his/her/its social security number or employment identification number.

 

    	17 

    	 

    

SECTION 5: PAYMENT FOR STOCK

 

5.1 General Rule. The entire
Exercise Price of Shares issued under the Plan shall be payable in full by cash or cashier's check for an amount equal to the aggregate
Exercise Price for the number of shares being purchased. Alternatively, in the sole discretion of the Plan Administrator and upon
such terms as the Plan Administrator shall approve, the Exercise Price may be paid by:

 

5.1.1 Cashless
Exercise. Provided the Company's Common Stock is publicly traded, a copy of instructions to a broker directing such broker to sell
the Shares for which this option is exercised, and to remit to the Company the aggregate Exercise Price of such option ("Cashless
Exercise");

 

5.1.2 Stock-For-Stock
Exercise. Paying all or a portion of the Exercise Price for the number of Shares being purchased by tendering Shares owned by the
Optionee, duly endorsed for transfer to the Company, with a Fair Market Value on the date of delivery equal to the Exercise Price
multiplied by the number of Shares with respect to which this option is being exercised (the "Purchase Price") or the
aggregate Purchase Price of the shares with respect to which this option or portion hereof is exercised ("Stock-for-Stock
Exercise"); or

 

5.1.3 Attestation
Exercise. By a stock for stock exercise by means of attestation whereby the Optionee identifies for delivery specific Shares already
owned by Optionee and receives a number of Shares equal to the difference between the Option Shares thereby exercised and the identified
attestation Shares ("Attestation Exercise").

 

5.2 Withholding Payment.
The Exercise Price shall include payment of the amount of all federal, state, local or other income, excise or employment taxes
subject to withholding (if any) by the Company or any parent or subsidiary corporation as a result of the exercise of a Stock Option.
The Optionee may pay all or a portion of the tax withholding by cash or check payable to the Company, or, at the discretion of
the Administrator, upon such terms as the Administrator shall approve, by (i) Cashless Exercise or Attestation Exercise; (ii) Stock-for-Stock
Exercise; (iii) in the case of an Option, by paying all or a portion of the tax withholding for the number of shares being purchased
by withholding shares from any transfer or payment to the Optionee ("Stock withholding"); or (iv) a combination of one
or more of the foregoing payment methods. Any shares issued pursuant to the exercise of an Option and transferred by the Optionee
to the Company for the purpose of satisfying any withholding obligation shall not again be available for purposes of the Plan.
The fair market value of the number of shares subject to Stock withholding shall not exceed an amount equal to the applicable minimum
required tax withholding rates.

 

5.3 Promissory Note. The
Plan Administrator, in its sole discretion, upon such terms as the Plan Administrator shall approve, may permit all or a portion
of the Exercise Price of Shares issued under the Plan to be paid with a full-recourse promissory note. However, in the event there
is a stated par value of the shares and applicable law requires, the par value of the shares, if newly issued, shall be paid in
cash or cash equivalents. The Shares shall be pledged as security for payment of the principal amount of the promissory note and
interest thereon, and shall be held in the possession of the Company until the promissory note is repaid in full. Subject to the
foregoing, the Plan Administrator (at its sole discretion) shall specify the term, interest rate, amortization requirements (if
any) and other provisions of such note.

 

    	18 

    	 

    

5.4 Exercise/Pledge. In
the discretion of the Plan Administrator, upon such terms as the Plan Administrator shall approve, payment may be made all or in
part by the delivery (on a form prescribed by the Plan Administrator) of an irrevocable direction to pledge Shares to a securities
broker or lender approved by the Company, as security for a loan, and to deliver all or part of the loan proceeds to the Company
in payment of all or part of the Exercise Price and any withholding taxes.

 

SECTION 6: TERM AND EXPIRATION

 

6.1 Basic Term. This option
shall expire and shall not be exercisable after the expiration of the earliest of (i) the Expiration Date specified in the Notice
of Stock Option Grant, (ii) three months after the date the Optionee's Service with the Company and its Subsidiaries terminates
if such termination is for any reason other than death, Disability or Cause, (iii) one year after the date the Optionee's Service
with the Company and its Subsidiaries terminates if such termination is a result of death or Disability, and (iv) if the Optionee's
Service with the Company and its Subsidiaries terminates for Cause, all outstanding Options granted to such Optionee shall expire
as of the commencement of business on the date of such termination. Outstanding Options that are not exercisable at the time of
termination of employment for any reason shall expire at the close of business on the date of such termination. The Plan Administrator
shall have the sole discretion to determine when this option is to expire. For any purpose under this Agreement, Service shall
be deemed to continue while the Optionee is on a bona fide leave of absence, if such leave to the extent required by applicable
law. To the extent applicable law does not require such a leave to be deemed to continue while the Optionee is on a bona fide leave
of absence, such leave shall be deemed to continue if, and only if, expressly provided in writing by the Administrator or a duly
authorized officer of the Company, Parent or Subsidiary for whom Optionee provides his or her services.

 

6.2 Exercise After Death.
All or part of this option may be exercised at any time before its expiration under Section 6.1 above by the executors or administrators
of the Optionee's estate or by any person who has acquired this option directly from the Optionee by beneficiary designation, bequest
or inheritance, but only to the extent that this option had become exercisable before the Optionee's death. When the Optionee dies,
this option shall expire immediately with respect to the number of Shares for which this option is not yet exercisable and with
respect to any Share that is subject to the Right of Repurchase (as such term is defined in below) (the "Restricted Stock").

 

6.3 Notice Concerning ISO
Treatment. If this option is designated as an ISO in the Notice of Stock Option Grant, it ceases to qualify for favorable tax treatment
as an ISO to the extent it is exercised (i) more than three months after the date the Optionee ceases to be an Employee for any
reason other than death or permanent and total disability (as defined in Section 22(e)(3) of the Code), (ii) more than 12 months
after the date the Optionee ceases to be an Employee by reason of such permanent and total disability, or (iii) after the Optionee
has been on a leave of absence for more than 90 days, unless the Optionee's reemployment rights are guaranteed by statute or by
contract.

 

 

 

    	19 

    	 

    

SECTION 7: RIGHT OF REPURCHASE

 

7.1 Option Repurchase Right.
Following a termination of the Optionee's Service, the Company shall have the option to repurchase the Optionee's vested and exercisable
options at a price equal to the Fair Market Value of the Stock underlying such options, less the Exercise Price (the "Option
Repurchase Right").

 

7.2 Stock Repurchase Right.
Unless they have become vested in accordance with the Notice of Stock Option Grant and Section 7.4 below, the stock acquired under
this Agreement initially shall be Restricted Stock and shall be subject to a right (but not an obligation) of repurchase by the
Company, which shall be exercisable at a price equal to the Exercise Price paid for the Restricted Stock (the "Stock Repurchase
Right"). Vested stock acquired under this Agreement shall be subject to a right (but not an obligation) of repurchase by the
Company, which shall be exercisable at a price equal to the Fair Market Value of the vested Stock.

 

7.3 Condition Precedent
to Exercise. The Option Repurchase Right and Stock Repurchase Rights (collectively, the "Right of Repurchase") shall
be exercisable over Restricted Stock only during the 90-day period next following the later of:

 

7.3.1 The date
when the Optionee's Service terminates for any reason, with or without Cause, including (without limitation) death or disability;
or

 

7.3.2 The date
when this option was exercised by the Optionee, the executors or administrators of the Optionee's estate, or any person who has
acquired this option directly from the Optionee by bequest, inheritance or beneficiary designation.

 

7.4 Lapse of Right of Repurchase.
The Right of Repurchase shall lapse with respect to the Shares subject to this option in accordance with the vesting schedule set
forth in the Notice of Stock Option Grant. In addition, the Right of Repurchase shall lapse and all of the remaining Restricted
Stock shall become vested if (i) a Change in Control occurs before the Optionee's Service terminates, and (ii) the Right of Repurchase
is not assigned to the entity that employs the Optionee immediately after the Change in Control or to its parent or subsidiary.
The Right of Repurchase shall lapse with respect to (i) Shares that are registered under a then currently effective registration
statement under applicable federal securities laws and the issuer is subject to the reporting requirements of Section 13 or 15(d)
of the Exchange Act or becomes an investment company registered or required to be registered under the Investment Company Act of
1940, or (ii) Shares for which a determination is made by counsel for the Company that such Exercise Price restrictions are not
required in the circumstances under applicable federal or state securities laws.

 

7.5 Exercise of Right of
Repurchase. The Company shall exercise the Right of Repurchase by written notice delivered to the Optionee prior to the expiration
of the 90-day period specified in Section 7.3 above. The notice shall set forth the date on which the repurchase is to be effected,
which must occur within 31 days of the notice. The certificate(s) representing the Restricted Stock to be repurchased shall, prior
to the close of business on the date specified for the repurchase, be delivered to the Company properly endorsed for transfer.
The Company shall, concurrently with the receipt of such certificate(s), pay to the Optionee the Purchase Price determined according
to this Section 7. Payment shall be made in cash or cash equivalents or by canceling indebtedness to the Company incurred by the
Optionee in the purchase of the Restricted Stock. The Right of Repurchase shall terminate with respect to any Restricted Stock
for which it has not been timely exercised pursuant to this Section 7.5.

    	20 

    	 

    

7.6 Rights of Repurchase
Adjustments. If there is any change in the number of outstanding shares of Stock by reason of a stock split, reverse stock split,
stock dividend, an extraordinary dividend payable in a form other than stock, recapitalization, combination or reclassification,
or a similar transaction affecting the Company's outstanding securities without receipt of consideration, then (i) any new, substituted
or additional securities or other property (including money paid other than as an ordinary cash dividend) distributed with respect
to any Restricted Stock (or into which such Restricted Stock thereby become convertible) shall immediately be subject to the Right
of Repurchase; and (ii) appropriate adjustments to reflect the distribution of such securities or property shall be made to the
number and/or class of the Restricted Stock and to the price per share to be paid upon the exercise of the Right of Repurchase;
provided, however, that the aggregate Purchase Price payable for the Restricted Stock shall remain the same.

 

7.7 Termination of Rights
as Stockholder. If the Company makes available, at the time and place and in the amount and form provided in this Agreement, the
consideration for the Restricted Stock to be repurchased in accordance with this Section 7, then after such time the person from
whom such Restricted Stock is to be repurchased shall no longer have any rights as a holder of such Restricted Stock (other than
the right to receive payment of such consideration in accordance with this Agreement). Such Restricted Stock shall be deemed to
have been repurchased in accordance with the applicable provisions hereof, whether or not the certificate(s) therefore have been
delivered as required by this Agreement.

 

7.8 Escrow. Upon issuance,
the certificates for Restricted Stock shall be deposited in escrow with the Company to be held in accordance with the provisions
of this Agreement. Any new, substituted or additional securities or other property described in Section 7.6 above shall immediately
be delivered to the Company to be held in escrow, but only to the extent the Shares are at the time Restricted Stock. All regular
cash dividends on Restricted Stock (or other securities at the time held in escrow) shall be paid directly to the Optionee and
shall not be held in escrow. Restricted Stock, together with any other assets or securities held in escrow hereunder, shall be
(i) surrendered to the Company for repurchase and cancellation upon the Company's exercise of its Right of Repurchase or Right
of First Refusal or (ii) released to the Optionee upon the Optionee's request to the extent the Shares are no longer Restricted
Stock (but not more frequently than once every six months). In any event, all Shares which have vested (and any other vested assets
and securities attributable thereto) shall be released within 60 days after the earlier of (i) the Optionee's cessation of Service
or (ii) the lapse of the Right of First Refusal.

 

SECTION 8: RIGHT OF FIRST REFUSAL

 

8.1 Right of First Refusal.
In the event that the Company's stock is not readily tradable on an established securities market and the Optionee proposes to
sell, pledge or otherwise transfer to a third party any Shares acquired under this Agreement, or any interest in such Shares, to
any person, entity or organization (the "Transferee") the Company shall have the Right of First Refusal with respect
to all (and not less than all) of such Shares (the "Right of First Refusal"). If the Optionee desires to transfer Shares
acquired under this Agreement, the Optionee shall give a written transfer notice ("Transfer Notice") to the Company describing
fully the proposed transfer, including the number of Shares proposed to be transferred, the proposed transfer price, the name and
address of the proposed Transferee and proof satisfactory to the Company that the proposed sale or transfer will not violate any
applicable federal or state securities laws. The Transfer Notice shall be signed both by the Optionee and by the proposed Transferee
and must constitute a binding commitment of both parties to the transfer of the Shares. The Company shall have the right to purchase
all, and not less than all, of the Shares on the terms of the proposal described in

    	21 

    	 

    

the Transfer Notice by delivery of a notice
of exercise of the Right of First Refusal within 30 days after the date when the Transfer Notice was received by the Company. The
Company's rights under this Section 8.1 shall be freely assignable, in whole or in part.

 

8.2 Additional Shares or
Substituted Securities. In the event of the declaration of a stock dividend, the declaration of an extraordinary dividend payable
in a form other than stock, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction
affecting the Company's outstanding securities without receipt of consideration, any new, substituted or additional securities
or other property (including money paid other than as an ordinary cash dividend) which are by reason of such transaction distributed
with respect to any Shares subject to this Section 8 or into which such Shares thereby become convertible shall immediately be
subject to this Section 8. Appropriate adjustments to reflect the distribution of such securities or property shall be made to
the number and/or class of the Shares subject to this Section 8.

 

8.3 Termination of Right
of First Refusal. Any other provision of this Section 8 notwithstanding, in the event that the Stock is readily tradable on an
established securities market when the Optionee desires to transfer Shares, the Company shall have no Right of First Refusal, and
the Optionee shall have no obligation to comply with the procedures prescribed by this Section 8.

 

8.4 Permitted Transfers.
This Section 8 shall not apply to a transfer (i) by gift to a member of the Participant's immediate family or (ii) by transfer
by instrument to a trust providing that the Option is to be passed to beneficiaries upon death of the Settlor. For purposes of
this Section 8.4, "immediate family" shall mean the Optionee's spouse (including a former spouse subject to terms of
a domestic relations order); child, stepchild, grandchild, child-in-law; parent, stepparent, grandparent, parent-in-law; sibling
and sibling-in-law, and shall include adoptive relationships.

 

8.5 Termination of Rights
as Stockholder. If the Company makes available, at the time and place and in the amount and form provided in this Agreement, the
consideration for the Shares to be purchased in accordance with this Section 8, then after such time the person from whom such
Shares are to be purchased shall no longer have any rights as a holder of such Shares (other than the right to receive payment
of such consideration in accordance with this Agreement). Such Shares shall be deemed to have been purchased in accordance with
the applicable provisions hereof, whether or not the certificate(s) therefore have been delivered as required by this Agreement.

 

SECTION 9: OBLIGATION TO SELL.

 

Notwithstanding anything
herein to the contrary, if at any time following Optionee's acquisition of Shares hereunder, stockholders of the Company owning
51% or more of the shares of the Company (on a fully diluted basis) (the "Control Sellers") enter into an agreement (including
any agreement in principal) to transfer all of their shares to any person or group of persons who are not affiliated with the Control
Sellers, such Control Sellers may require each stockholder who is not a Control Seller (a "Non-Control Seller") to sell
all of their shares to such person or group of persons at a price and on terms and conditions the same as those on which such Control
Sellers have agreed to sell their shares, other than terms and conditions relating to the performance or non-performance of services.
For the purposes of the preceding sentence, an affiliate of a Control Seller is a person who controls, which is controlled by,
or which is under common control with, the Control Seller.

    	22 

    	 

    

SECTION 10: STOCKHOLDERS AGREEMENT

 

As a condition to the transfer
of Stock pursuant to this Stock Option Agreement, the Administrator, in its sole and absolute discretion, may require the Participant
to execute and become a party to any agreement by and among the Company and any of its stockholders which exists on or after the
Date of Grant (the "Stockholders Agreement"). If the Participant becomes a party to a Stockholders Agreement, in addition
to the terms of the Plan and this Stock Option Agreement, the terms and conditions of Stockholders Agreement shall govern Participant's
rights in and to the Stock; and if there is any conflict between the provisions of the Stockholders Agreement and the Plan or any
conflict between the provisions of the Stockholders Agreement and this Stock Option Agreement, the provisions of the Stockholders
Agreement shall be controlling. Notwithstanding anything to the contrary in this Section 10, if the Stockholders Agreement contains
any provisions which would violate Delaware corporate law if applied to the Participant, the terms of the Plan and this Stock Option
Agreement shall govern the Participant's rights with respect to such provisions.

 

SECTION 11: LEGALITY OF INITIAL ISSUANCE

 

No Shares shall be issued
upon the exercise of this option unless and until the Company has determined that:

 

11.1 It and the Optionee
have taken any actions required to register the Shares, provided the Stock is publicly traded, under the Securities Act of 1933,
as amended (the "Securities Act"), or to perfect an exemption from the registration requirements thereof;

 

11.2 Any applicable listing
requirement of any stock exchange on which Stock is listed has been satisfied; and

 

11.3 Any other applicable
provision of state or federal law has been satisfied.

 

SECTION 12: NO REGISTRATION RIGHTS

 

The Company may, but shall
not be obligated to, register or qualify the sale of Shares under the Securities Act or any other applicable law. The Company shall
not be obligated to take any affirmative action in order to cause the sale of Shares under this Agreement to comply with any law.

 

SECTION 13: RESTRICTIONS ON TRANSFER

 

13.1 Securities Law Restrictions.
Regardless of whether the offering and sale of Shares under the Plan have been registered under the Securities Act or have been
registered or qualified under the securities laws of any state, the Company, at its discretion, may impose restrictions upon the
sale, pledge or other transfer of such Shares (including the placement of appropriate legends on stock certificates or the imposition
of stop-transfer instructions) if, in the judgment of the Company, such restrictions are necessary or desirable in order to achieve
compliance with the Securities Act, the securities laws of any state or any other law.

 

13.2 Market Stand-Off.
In the event of an underwritten public offering by the Company of its equity securities pursuant to an effective registration statement
filed under the Act, including the Company's initial public offering (a "Public Offering"), the Optionee shall not transfer
for value any shares of Stock without the prior written consent of the Company or its

    	23 

    	 

    

underwriters, for such period of time from
and after the effective date of such registration statement as may be requested by the Company or such underwriters (the "Market
Stand-Off"). The Market Stand-off shall be in effect for such period of time following the date of the final prospectus for
the offering as may be requested by the Company or such underwriters. In the event of the declaration of a stock dividend, a spin-off,
a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company's outstanding
securities without receipt of consideration, any new, substituted or additional securities which are by reason of such transaction
distributed with respect to any Shares subject to the Market Stand-Off, or into which such Shares thereby become convertible, shall
immediately be subject to the Market Stand-Off. In order to enforce the Market Stand-Off, the Company may impose stop-transfer
instructions with respect to the Shares acquired under this Agreement until the end of the applicable stand-off period.

 

13.3 Investment Intent
at Grant. The Optionee represents and agrees that the Shares to be acquired upon exercising this option will be acquired for investment,
and not with a view to the sale or distribution thereof.

 

13.4 Investment Intent
at Exercise. In the event that the sale of Shares under the Plan is not registered under the Securities Act but an exemption is
available which requires an investment representation or other representation, the Optionee shall represent and agree at the time
of exercise that the Shares being acquired upon exercising this option are being acquired for investment, and not with a view to
the sale or distribution thereof, and shall make such other representations as are deemed necessary or appropriate by the Company
and its counsel.

 

13.5 Legends. All certificates
evidencing Shares purchased under this Agreement in an unregistered transaction shall bear the following legend (and such other
restrictive legends as are required or deemed advisable under the provisions of any applicable law):

 

"THE SHARES REPRESENTED HEREBY HAVE NOT
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT AN
EFFECTIVE REGISTRATION THEREOF UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH
REGISTRATION IS NOT REQUIRED."

 

13.6 Removal of Legends.
If, in the opinion of the Company and its counsel, any legend placed on a stock certificate representing Shares sold under this
Agreement no longer is required, the holder of such certificate shall be entitled to exchange such certificate for a certificate
representing the same number of Shares but without such legend.

 

13.7 Administration. Any
determination by the Company and its counsel in connection with any of the matters set forth in this Section 13 shall be conclusive
and binding on the Optionee and all other persons.

 

SECTION 14: MISCELLANEOUS PROVISIONS

 

14.1 Rights as a Stockholder.
Neither the Optionee nor the Optionee's representative shall have any rights as a stockholder with respect to any Shares subject
to this option until the Optionee or the Optionee's representative becomes entitled to receive such Shares by filing a notice of
exercise and paying the Exercise Price pursuant to Section 4 and Section 5 hereof.

 

    	24 

    	 

    

14.2 Adjustments. If there
is any change in the number of outstanding shares of Stock by reason of a stock split, reverse stock split, stock dividend, recapitalization,
combination or reclassification, then (i) the number of shares subject to this option and (ii) the Exercise Price of this option,
in effect prior to such change, shall be proportionately adjusted to reflect any increase or decrease in the number of issued shares
of Stock; provided, however, that any fractional shares resulting from the adjustment shall be eliminated.

 

14.3 No Retention Rights.
Nothing in this option or in the Plan shall confer upon the Optionee any right to continue in Service for any period of specific
duration or interfere with or otherwise restrict in any way the rights of the Company (or any Parent or Subsidiary employing or
retaining the Optionee) or of the Optionee, which rights are hereby expressly reserved by each, to terminate his or her Service
at any time and for any reason, with or without Cause.

 

14.4 Notice. Any notice
required by the terms of this Agreement shall be given in writing and shall be deemed effective upon personal delivery or upon
deposit with the United States Postal Service, by registered or certified mail, with postage and fees prepaid. Notice shall be
addressed the Optionee at the address set forth in the records of the Company. Notice shall be addressed to the Company at:

 

BIO LAB NATURALS,
INC.

Attn: W. Edward Nichols, CEO

201 Columbine St., 3rd Floor, Suite 11

Denver, CO 80206

 

14.5 Entire Agreement.
The Notice of Stock Option Grant, this Agreement and the Plan constitute the entire contract between the parties hereto with regard
to the subject matter hereof. They supersede any other agreements, representations or understandings (whether oral or written and
whether express or implied) that relate to the subject matter hereof.

 

14.6 Choice of Law. THIS
AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE WITHOUT REGARD TO ITS CHOICE
OF LAWS PROVISIONS, AS DELAWARE LAWS ARE APPLIED TO CONTRACTS ENTERED INTO AND PERFORMED IN SUCH STATE.

 

14.7 Attorneys' Fees. In
the event that any action, suit or proceeding is instituted upon any breach of this Agreement, the prevailing party shall be paid
by the other party thereto an amount equal to all of the prevailing party's costs and expenses, including attorneys' fees incurred
in each and every such action, suit or proceeding (including any and all appeals or petitions therefrom). As used in this Agreement,
"attorneys' fees" shall mean the full and actual cost of any legal services actually performed in connection with the
matter involved calculated on the basis of the usual fee charged by the attorney performing such services and shall not be limited
to "reasonable attorneys' fees" as defined in any statute or rule of court.

    	25 

    	 

    

EXHIBIT A

TO

BIO LAB NATURALS, INC.

STOCK OPTION AND AWARD INCENTIVE PLAN:

STOCK OPTION AGREEMENT

ANNEX I

 

 

NOTICE OF EXERCISE

 

(To be signed only upon exercise of the Option)

 

BIO LAB NATURALS,
INC.

Attn: W. Edward Nichols, CEO

201 Columbine St., 3rd Floor, Suite 11

Denver, CO 80206

 

The undersigned, the holder of the enclosed
Stock Option Agreement, hereby irrevocably elects to exercise the purchase rights represented by the Option and to purchase thereunder
__________* shares of Common Stock of BIO LAB NATURALS, INC. (the "Company"), and herewith encloses payment of $_______
and/or _________ shares of the Company's common stock in full payment of the purchase price of such shares being purchased.

 

 

Dated:

 

------------------------------

 

NOTICE: YOUR STOCK MAY BE SUBJECT TO RESTRICTIONS
AND FORFEITABLE UNDER THE NOTICE OF STOCK OPTION GRANT AND STOCK OPTION AGREEMENT

 

(Signature must conform in all respects to
name of holder as specified on the face of the Option)

 

 

 

--------------------------------------------------------------

 

--------------------------------------------------------------

(Please Print Name)

 

 

--------------------------------------------------------------

 

--------------------------------------------------------------

(Address)

 

 

* Insert here the number of shares called for
on the face of the Option, or, in the case of a partial exercise, the number of shares being exercised, in either case without
making any adjustment for additional Common Stock of the Company, other securities or property that, pursuant to the adjustment
provisions of the Option, may be deliverable upon exercise.

    	26 

    	 

    

FORM OF RESOLUTIONS FOR OPTION GRANTS

 

 

RESOLUTIONS ADOPTED BY UNANIMOUS WRITTEN CONSENT

OF THE BOARD OF DIRECTORS OF

BIO LAB NATURALS, INC.

 

As of ______________, 20__

 

The undersigned directors, constituting the
entire board of directors (the "Board") of BIO LAB NATURALS, INC., a Delaware Corporation (the "Company"),
hereby take the following actions, adopt the following resolutions, and transact the following business, by written consent without
a meeting, as of the date above written, pursuant to the applicable corporate laws of the State of Delaware and the Company's Bylaws.

 

WHEREAS, the Company previously adopted the
BIO LAB NATURALS, INC. STOCK OPTION AND AWARD INCENTIVE PLAN (the "Plan"), and has delegated the responsibility to administer
the Plan to the Board;

 

WHEREAS, Two Million (2,000,000) shares of
Common Stock of the Company were originally reserved for issuance under the Plan;

 

WHEREAS, as of the date hereof, _____________
shares remain available for issuance under the Plan; and

 

WHEREAS, the Board has determined that it is
in the best interests of this Company and its stockholders to provide, under the Plan, equity incentives to those employees, directors
and/or consultants of the Company identified below.

 

NOW, THEREFORE, BE IT RESOLVED, that the persons
listed on the Exhibit A, which is attached hereto and incorporated herein by reference, which exhibit was reviewed by the Board
and shall be included with this Consent, are hereby granted, as of the date hereof, an option (the "Option") to purchase
the number of shares with the vesting schedule and exercise price as set forth in Exhibit A;

 

RESOLVED FURTHER, that each of the Options
shall be either a Non-Qualified Stock Option or an ISO (as such terms are defined in the Plan) as specified in Exhibit A;

 

RESOLVED FURTHER, that the Options shall be
evidenced by stock option agreements and be subject to the restrictions (including transfer and/or repurchase rights), if any,
set forth in such stock option agreements;

 

RESOLVED FURTHER, that the Options shall be
granted pursuant to the exemptions provided under Section 701 of the Securities Act Rules and Delaware Securities Laws;

 

RESOLVED FURTHER, that there is hereby reserved
and set aside under the Plan the number of shares adequate to cover the shares underlying the Options granted herein; and

 

RESOLVED FURTHER, that the officers of this
Company, and each of them, be, and they hereby are, authorized, directed and empowered for and on behalf of the Company to do or
cause to be done all such acts and things and to sign, deliver and/or file all such documents and notices

    	27 

    	 

    

as any of such officers may deem necessary
or advisable in order to carry out and perform the foregoing resolutions and the intention thereof.

 

The Secretary of the Corporation is directed
to file the original executed copy of this Consent with the minutes of proceedings of the Board.

 

IN WITNESS WHEREOF, each of the undersigned
has executed this consent as of the date first written above.

 

DIRECTORS:

 

	 	 	 
	W. Edward Nichols, Director	 	Darrell Avey, Director
	 	 	 
	 	 	 
	Jeremy Ostler, Director	 	Calvin D. Smiley, Sr., Director

 

 

 

    	28 

    	 

    

EXHIBIT A

TO

FORM OF RESOLUTIONS FOR OPTION GRANTS

 

 

 

Stock Option Grant Information

 

	Name	No. Shares	ISO or NQSO	Exercise Price*	Vesting Schedule
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 
	 	 	 	 	 

 

 

* In the case of an ISO, the per share exercise
price must be at least 100% of the Fair Market Value (as such term is defined in the Plan) of the underlying share as of the date
of grant. In the case of a NQSO, the per share exercise price must be at least 85% of the Fair Market Value of the underlying share
as of the date of grant.

 

    	29 

    	 

    

STOCK PURCHASE AGREEMENT

 

 

 

 

 

    	30 

    	 

    

 

 

 

 

STOCK PURCHASE CERTIFICATE

 

THIS IS TO CERTIFY that BIO LAB NATURALS, INC.,
a Delaware corporation (the "Company"), has offered you (the "Purchaser") the right to purchase Common Stock
(the "Stock" or "Shares") of the Company under its BIO LAB NATURALS, INC. STOCK OPTION AND AWARD INCENTIVE
PLAN (the "Plan"), as follows:

 

	Name of Purchaser:	 
	Address of Purchaser:	 
	 	 
	Number of Shares:	 
	Purchase Price:	$
	Offer Grant Date:	 
	Offer Expiration Date:	15 days after the Offer Grant Date
	Vesting Commencement Date:	 
	Vesting Schedule:	 
	 	 

 

 

By your signature and the signature of the
Company's representative below, you and the Company agree to be bound by all of the terms and conditions of the Stock Purchase
Agreement, which is attached hereto as Annex I and the Plan (both incorporated herein by this reference as if set forth in full
in this document). By executing this Agreement, Purchaser hereby irrevocably elects to exercise the purchase rights granted pursuant
to the Stock Purchase Agreement and to purchase ________ shares of Stock of BIO LAB NATURALS, INC., and herewith encloses payment
of $____________ in payment of the purchase price of the shares being purchased.

 

PURCHASER: BIO LAB NATURALS, INC.

 

By:_________________________________ By:______________________

W. Edward Nichols

Print Name:_________________________Its:
CEO

 

 

 

 

    	31 

    	 

    

ANNEX I

to

STOCK PURCHASE AGREEMENT

 

 

THE STOCK GRANTED PURSUANT TO THIS AGREEMENT
HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE SOLD, PLEDGED, OR OTHERWISE TRANSFERRED WITHOUT
AN EFFECTIVE REGISTRATION UNDER SUCH ACT OR AN OPINION OF COUNSEL, SATISFACTORY TO THE COMPANY AND ITS COUNSEL, THAT SUCH REGISTRATION
IS NOT REQUIRED.

 

 

BIO LAB NATURALS, INC.

STOCK OPTION AND AWARD INCENTIVE PLAN:

STOCK PURCHASE AGREEMENT

 

This Stock Purchase Agreement (this "Agreement")
is made and entered into on the execution date of the Stock Purchase Certificate to which it is attached (the "Certificate"),
by and between BIO LAB NATURALS, INC., a Delaware corporation (the "Company"), and the Director, Employee or Consultant
("Purchaser") named in the Certificate.

 

Pursuant to the BIO LAB NATURALS, INC. STOCK
OPTION AND AWARD INCENTIVE PLAN (the "Plan"), the Administrator of the Plan has authorized the grant to Purchaser of
the right to purchase shares of the Company's Common Stock, upon the terms and subject to the conditions set forth in this Agreement
and in the Plan. Capitalized terms not otherwise defied herein shall have the meanings ascribed to them in the Plan.

 

SECTION 1: THE OFFER.

 

1.1 Offer of the Stock.
The Company hereby offers to sell to purchaser the number of shares of stock set forth in the certificate at the price and subject
to the restrictions set forth in this Agreement (the shares of stock which you purchase under this agreement are referred to as
the "Stock" or "Shares").

 

1.2 Purchase Price. The
Purchase Price for the Stock is set forth in the Certificate.

 

1.3 Payment For The Stock.
Purchaser may pay for the stock by delivering to the company the purchase price in the form of either (i) cash or cashier's check
or (ii) your promissory note, in the form of the Promissory Note attached to this agreement as Exhibit A. If Purchaser pays for
the stock by delivery of the Promissory Note, Purchaser must also deliver to the company at the same time one executed copy of
both the Security Agreement attached as Exhibit B and the Stock Assignment attached as Exhibit C.

 

1.4 Expiration of Offer.
This offer expires at 5:00 o'clock p.m. on the date set forth in the certificate.

 

    	32 

    	 

    

SECTION 2: ACCEPTANCE OF THE OFFER.

 

There is no obligation to exercise the rights
granted to you under this Agreement, in whole or in part. Purchaser may purchase fewer shares than the number offered to Purchaser
in this Agreement. If Purchaser decides to accept the offer and purchase any shares offered, Purchaser must do the following:

 

2.1 Complete Documents.
Complete, sign and date one copy of the Certificate, and, if Purchaser is paying by delivery of a promissory note, one copy each
of the attached Promissory Note, Security Agreement and Stock Assignment;

 

2.2 Spousal Consent. If
Purchaser is married, Purchaser must have his or her spouse sign and date one copy of the attached Spousal Consent; and

 

2.3 Deliver to Company.
Deliver to the Company on or before the time the offer expires, the signed copy of this Agreement, the Spousal Consent, and payment
for the Stock, in cash, by cashier's check or by the Promissory Note. If Purchaser is paying for the stock by the Promissory Note,
Purchaser must also deliver to the Company the executed original Promissory Note, Security Agreement and Stock Assignment.

 

Purchaser should retain a copy of all of the
signed documents for his or her files, and if Purchaser does so, Purchaser should mark the retained copy of the Promissory Note
"COPY." THE SIGNED PROMISSORY NOTE IS A NEGOTIABLE INSTRUMENT AND IS ENFORCEABLE AGAINST PURCHASER BY ANY HOLDER OF THE
PROMISSORY NOTE, AND ANY ADDITIONAL SIGNED COPIES WHICH ARE NOT MARKED "COPY" MAY ALSO BE NEGOTIABLE INSTRUMENTS WHICH
ARE ENFORCEABLE AGAINST PURCHASER BY THEIR HOLDER.

 

SECTION 3: RESTRICTIONS ON THE STOCK.

 

3.1 Restrictions on Transfer
of Shares. Purchaser shall not sell, make any short sale of, loan, hypothecate, pledge, grant any option for the repurchase of,
or otherwise dispose or transfer for value (each a "Transfer") or otherwise agree to engage in any of the foregoing transactions
with respect to any shares of Stock. The Company shall not be required to register any such Transfer and the Company may instruct
its transfer agent not to register any such Transfer, unless and until all of the following events shall have occurred:

 

3.1.1 The Company
has declined to exercise the right of first refusal provided for in Section 5 hereof;

 

3.1.2 The Shares
are Transferred pursuant to and in conformity with: (i) (x) an effective registration statement filed with the Securities and Exchange
Commission (the "Commission") pursuant to the Securities Act of 1933, as amended (the "Act") or (y) an exemption
from registration under the Act; and (ii) the securities laws of any state of the United States; and

 

3.1.3 Purchaser
has, prior to the Transfer of such Shares, and if requested by the Company, provided all relevant information to the Company's
counsel so that upon the Company's request, the Company's counsel is able to deliver, and actually prepares and delivers to the
Company a written opinion that the proposed Transfer is: (i) (x) pursuant to a registration statement which has been filed with
the Commission and is then effective

    	33 

    	 

    

or (y) exempt from registration under
the Act as then in effect, and the Rules and Regulations of the Commission thereunder; and (ii) is either qualified or registered
under any applicable state securities laws, or exempt from such qualification or registration. The Company shall bear all reasonable
costs of preparing such opinion.

 

3.2 Additional Restrictions
on Transfer of Non-Vested Shares. Purchaser agrees, for himself or herself and for his or her heirs, successors and assigns, that
Purchaser shall have no right or power under any circumstance to Transfer any interest in shares of the Stock which are "Non-Vested
Shares," as determined by the schedule set forth in the Certificate, except to the Company. As used in this Agreement, "Vested
Shares" means all shares of the Stock which Purchaser has the right to Transfer at a specified point in time and "Non-Vested
Shares" means all shares of the Stock which Purchaser does not have the right to Transfer at a specified point in time. The
Certificate sets forth the vesting schedule.

 

3.3 Company's Repurchase
Right.

 

3.3.1 Scope of
Repurchase Right. Unless they have become vested, the Shares acquired under this Agreement initially shall be "Restricted
Stock" and shall be subject to a right (but not an obligation) of repurchase by the Company (the "Repurchase Right").
The Purchaser shall not transfer, assign, encumber or otherwise dispose of any Restricted Stock, except as provided in the following
sentence. The Purchaser may transfer Restricted Stock:

 

3.3.1.1 By testament
or intestate succession or by transfer by instrument to a trust providing that the Restricted Stock is to be passed to one or more
beneficiaries upon death of the Settlor; or

 

3.3.1.2 To the
Purchaser's "immediate family," as that term is defined in the Plan (together, "Transferee").

 

Provided, however,
in either case the Transferee must agree in writing on a form prescribed by the Company to be bound by all provisions of this Agreement.
If the Purchaser transfers any Restricted Stock, then this Section 3 will apply to the Transferee to the same extent as to the
Purchaser.

 

3.3.2 Exercise
Period. The Repurchase Right shall be exercisable only during the 90-day period following the later of the date when the Purchaser's
service as an Employee, outside Director or Consultant ("Service") terminates for any reason, with or without cause,
including (without limitation) death or disability.

 

3.3.3 Non Applicability
and Lapse of Repurchase Right. The Repurchase Right shall lapse with respect to the Shares in accordance with the vesting schedule
set forth in the Certificate. In addition, the Repurchase Right shall lapse and all of such Stock shall become vested if (i) a
Change in Control occurs before the Purchaser's Service terminates and (ii) the options are not assumed by, or Repurchase Right
is not assigned to, the entity that employs the Participant immediately after the Change in Control or to its parent or subsidiary.

 

The Repurchase
Right shall not exist with respect to shares of Stock that have been registered under a then currently effective registration statement
under applicable federal securities laws and the issuer is subject to the reporting requirements of Section

    	34 

    	 

    

13 or 15(d) of the Exchange Act or
becomes an investment company registered or required to be registered under the Investment Company Act of 1940, or (ii) a determination
is made by counsel for the Company that such Exercise Price restrictions are not required in the circumstances under applicable
federal or state securities laws.

 

3.3.4 Repurchase
Price. Following a termination of the Participant's Service, which does not result from the Company's termination of Service for
Cause, the Repurchase Right shall be exercisable at a price equal to (i) the Fair Market Value of vested Stock and (ii) the Purchase
Price of unvested Stock. Following the termination of the Participant's Service for Cause, the Repurchase Right shall be exercisable
as to both vested and unvested Shares at a price equal to the Purchase Price as set forth in the Certificate.

 

3.3.5 Rights
of Repurchase Adjustments. If there is any change in the number of outstanding shares of Stock by reason of a stock split, reverse
stock split, stock dividend, an extraordinary dividend payable in a form other than stock, recapitalization, combination or reclassification,
or a similar transaction affecting the Company's outstanding securities without receipt of consideration, then (i) any new, substituted
or additional securities or other property (including money paid other than as an ordinary cash dividend) distributed with respect
to any Restricted Stock (or into which such Restricted Stock thereby become convertible) shall immediately be subject to the Right
of Repurchase; and (ii) appropriate adjustments to reflect the distribution of such securities or property shall be made to the
number and/or class of the Restricted Stock and to the price per share to be paid upon the exercise of the Right of Repurchase;
provided, however, that the aggregate Purchase Price payable for the Restricted Stock shall remain the same.

 

3.3.6 Escrow.
Upon issuance, the certificates for Restricted Stock shall be deposited in escrow with the Company to be held in accordance with
the provisions of this Agreement. Any new, substituted or additional securities or other property described in Section 3.3.5 above
shall immediately be delivered to the Company to be held in escrow, but only to the extent the Shares are at the time Restricted
Stock. All regular cash dividends on Restricted Stock (or other securities at the time held in escrow) shall be paid directly to
the Purchaser and shall not be held in escrow. Restricted Stock, together with any other assets or securities held in escrow hereunder,
shall be (i) surrendered to the Company for repurchase and cancellation upon the Company's exercise of its Right of Repurchase
or Right of First Refusal or (ii) released to the Purchaser upon the Purchaser's request to the extent the Shares are no longer
Restricted Stock (but not more frequently than once every six months). In any event, all Shares which have vested (and any other
vested assets and securities attributable thereto) shall be released within 60 days after the earlier of (i) the Purchaser's cessation
of Service or (ii) the lapse of the Right of First Refusal.

 

3.4 Retention of Non-Vested
Shares. Purchaser shall immediately deliver to the Company each certificate representing Non-Vested Shares issued to Purchaser
hereunder, or deemed to be issued to Purchaser hereunder, together with the collateral instruments of transfer executed in blank,
to be held by the Company until such time as all shares represented by that certificate are Vested Shares and any indebtedness
with respect to those shares has been paid in full; provided, however, that if the Company holds a certificate representing Vested
Shares and Non-Vested Shares, and any indebtedness with respect to the Vested Shares has been paid in full, upon Purchaser's request
the Company will cause a certificate representing the Vested Shares to be

    	35 

    	 

    

delivered to Purchaser, but the Company will
retain any certificate representing the Non-Vested Shares.

 

3.5 Non-Complying Transfers.
Every attempted Transfer of any shares of the Stock in violation of this Section 3 shall be null and void ab initio, and of no
force or effect.

 

SECTION 4: LEGENDS ON STOCK CERTIFICATES.

 

Purchaser agrees that the Company may place
on each certificate representing Shares the following legend:

 

"THE SECURITIES EVIDENCED BY THIS CERTIFICATE
MAY NOT BE SOLD, TRANSFERRED, ASSIGNED, PLEDGED, HYPOTHECATED OR OTHERWISE DISPOSED OF EXCEPT IN ACCORDANCE WITH THE TERMS OF AN
AGREEMENT BETWEEN THE ISSUER AND THE REGISTERED HOLDER OF THIS CERTIFICATE, WHICH AGREEMENT PROVIDES, AMONG OTHER THINGS, THAT
THE ISSUER HAS A RIGHT TO REPURCHASE THE SECURITIES EVIDENCED BY THIS CERTIFICATE. A COPY OF THAT AGREEMENT IS ON FILE AT THE PRINCIPAL
OFFICE OF THE ISSUER."

 

SECTION 5: RIGHT OF FIRST REFUSAL.

 

5.1 Right of First Refusal.
In the event that the Stock is not readily tradable on an established securities market and the Purchaser proposes to sell, pledge
or otherwise transfer to a third party any Shares acquired under this Agreement, or any interest in such Shares, to any person,
entity or organization (the "Transferee") the Company shall have the Right of First Refusal with respect to all (and
not less than all) of such Shares (the "Right of First Refusal"). If the Purchaser desires to transfer Shares acquired
under this Agreement, the Purchaser shall give a written transfer notice ("Transfer Notice") to the Company describing
fully the proposed transfer, including the number of Shares proposed to be transferred, the proposed transfer price, the name and
address of the proposed Transferee and proof satisfactory to the Company that the proposed sale or transfer will not violate any
applicable federal or state securities laws. The Transfer Notice shall be signed both by the Purchaser and by the proposed Transferee
and must constitute a binding commitment of both parties to the transfer of the Shares. The Company shall have the right to purchase
all, and not less than all, of the Shares on the terms of the proposal described in the Transfer Notice by delivery of a notice
of exercise of the Right of First Refusal within 30 days after the date when the Transfer Notice was received by the Company. The
Company's rights under this Section 5 shall be freely assignable, in whole or in part.

 

5.2 Additional Shares or
Substituted Securities. In the event of the declaration of a stock dividend, the declaration of an extraordinary dividend payable
in a form other than stock, a spin-off, a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction
affecting the Company's outstanding securities without receipt of consideration, any new, substituted or additional securities
or other property (including money paid other than as an ordinary cash dividend) which are by reason of such transaction distributed
with respect to any Shares subject to this Section 5 or into which such Shares thereby become convertible shall immediately be
subject to this Section 5. Appropriate adjustments to reflect the distribution of such securities or property shall be made to
the number and/or class of the Shares subject to this Section 5.

 

5.3 Termination of Right
of First Refusal. Any other provision of this Section 5 notwithstanding, in the event that the Stock is readily tradable on an
established securities market

    	36 

    	 

    

when the Purchaser desires to transfer Shares,
the Company shall have no Right of First Refusal, and the Purchaser shall have no obligation to comply with the procedures prescribed
by this Section 5.

 

5.4 Permitted Transfers.
This Section 5 shall not apply to a transfer (i) by gift to a member of the Participant's immediate family or (ii) by transfer
by instrument to a trust providing that the Shares is to be passed to beneficiaries upon death of the Settlor. For purposes of
this Section 5.4, "immediate family" shall mean the Purchaser's spouse (including a former spouse subject to terms of
a domestic relations order); child, stepchild, grandchild, child-in-law; parent, stepparent, grandparent, parent-in-law; sibling
and sibling-in-law, and shall include adoptive relationships.

 

5.5 Termination of Rights
as Stockholder. If the Company makes available, at the time and place and in the amount and form provided in this Agreement, the
consideration for the Shares to be purchased in accordance with this Section 5, then after such time the person from whom such
Shares are to be purchased shall no longer have any rights as a holder of such Shares (other than the right to receive payment
of such consideration in accordance with this Agreement). Such Shares shall be deemed to have been purchased in accordance with
the applicable provisions hereof, whether or not the certificate(s) therefor have been delivered as required by this Agreement.

 

SECTION 6: OBLIGATION TO SELL.

 

Notwithstanding anything herein to the contrary,
if at any time following Purchaser's acquisition of Shares hereunder, stockholders of the Company owning 51% or more of the shares
of the Company (on a fully diluted basis) (the "Control Sellers") enter into an agreement (including any agreement in
principal) to transfer all of their shares to any person or group of persons who are not affiliated with the Control Sellers, such
Control Sellers may require each stockholder who is not a Control Seller (a "Non-Control Seller") to sell all of their
shares to such person or group of persons at a price and on terms and conditions the same as those on which such Control Sellers
have agreed to sell their shares, other than terms and conditions relating to the performance or non-performance of services. For
the purposes of the preceding sentence, an affiliate of a Control Seller is a person who controls, which is controlled by, or which
is under common control with, the Control Seller.

 

SECTION 7: STOCKHOLDERS AGREEMENT.

 

As a condition to the transfer of Stock pursuant
to this Stock Purchase Agreement, the Administrator, in its sole and absolute discretion, may require the Participant to execute
and become a party to any agreement by and among the Company and any of its stockholders which exists on or after the Date of Grant
(the "Stockholders Agreement"). If the Participant becomes a party to a Stockholders Agreement, in addition to the terms
of the Plan and this Stock Purchase Agreement, the terms and conditions of Stockholders Agreement shall govern Participant's rights
in and to the Stock; and if there is any conflict between the provisions of the Stockholders Agreement and the Plan or any conflict
between the provisions of the Stockholders Agreement and this Stock Purchase Agreement, the provisions of the Stockholders Agreement
shall be controlling. Notwithstanding anything to the contrary in this Section 7, if the Stockholders Agreement contains any provisions
which would violate Delaware law if applied to the Participant, the terms of the Plan and this Stock Purchase Agreement shall govern
the Participant's rights with respect to such provisions.

 

    	37 

    	 

    

SECTION 8: WAIVER OF RIGHTS TO PURCHASE STOCK.

 

By signing this Agreement, Purchaser acknowledges
and agrees that neither the Company nor any other person or entity is under any obligation to sell or transfer to Purchaser any
option or equity security of the Company, other than the shares of Stock subject to this Agreement and any other right or option
to purchase Stock which was previously granted in writing to Purchaser by the Board (or a committee thereof). By signing this Agreement,
except as provided in the immediately preceding sentence, Purchaser specifically waives all rights he or she may have had prior
to the date of this Agreement to receive any option or equity security of the Company.

 

SECTION 9: INVESTMENT INTENT.

 

Purchaser represents and agrees that if he
or she purchases the Stock in whole or in part and if at the time of such purchase the Stock has not been registered under the
Act, that he or she will acquire the Stock upon such purchase for the purpose of investment and not with a view to the distribution
of such Stock and upon each purchase, he or she will furnish to the Company a written statement to such effect.

 

SECTION 10: GENERAL PROVISIONS.

 

10.1 Further Assurances.
Purchaser shall promptly take all actions and execute all documents requested by the Company which the Company deems to be reasonably
necessary to effectuate the terms and intent of this Agreement. Any sale or transfer of the Stock to Purchaser by the Company shall
be made free of any and all claims, encumbrances, liens and restrictions of every kind, other than those imposed by this Agreement.

 

10.2 Notices. All notices,
requests, demands and other communications under this Agreement shall be in writing and shall be given to the parties hereto as
follows:

 

10.2.1 If to
the Company, to:

 

BIO
LAB NATURALS, INC.

Attn: W. Edward Nichols, CEO

201 Columbine St., 3rd
Floor, Suite 11

Denver, CO 80206

10.2.2 If to
Purchaser, to the address set forth in the records of the Company.

 

10.2.3 Any such
notice request, demand or other communication shall be effective (i) if given by mail, 72 hours after such communication is deposited
in the mail by first-class certified mail, return receipt requested, postage pre-paid, addressed as aforesaid, or (ii) if given
by any other means, when delivered at the address specified in this Section 10.2.

 

10.3 Transfer of Rights
under this Agreement. The Company may at any time transfer and assign its rights and delegate its obligations under this Agreement
to any other person, Company, firm or entity, including its officers, Directors and stockholders, with or without consideration.

 

10.4 Purchase Rights Non
Transferable. Purchaser may not sell, transfer, assign or otherwise dispose of any rights hereunder except by testament or the
laws of descent and

    	38 

    	 

    

distribution and the rights hereunder may be
exercised during the lifetime of Purchaser only by the Purchaser or by his or her guardian or legal representative.

 

10.5 Market Stand-Off.
In the event of an underwritten public offering by the Company of its equity securities pursuant to an effective registration statement
filed under the Act, including the Company's initial public offering (a "Public Offering"), Purchaser shall not transfer
for value any shares of Stock without the prior written consent of the Company or its underwriters, for such period of time from
and after the effective date of such registration statement as may be requested by the Company or such underwriters (the "Market
Stand-Off"). The Market Stand-Off shall be in effect for such period of time following the date of the final prospectus for
the offering as may be requested by the Company or such underwriters. In the event of the declaration of a stock dividend, a spin-off,
a stock split, an adjustment in conversion ratio, a recapitalization or a similar transaction affecting the Company's outstanding
securities without receipt of consideration, any new, substituted or additional securities which are by reason of such transaction
distributed with respect to any Shares subject to the Market Stand-Off, or into which such Shares thereby become convertible, shall
immediately be subject to the Market Stand-Off. In order to enforce the Market Stand-Off, the Company may impose stop-transfer
instructions with respect to the Shares acquired under this Agreement until the end of the applicable stand-off period.

 

10.6 Adjustment. If there
is any change in the number of outstanding shares of Stock by reason of a stock split, reverse stock split, stock dividend, an
extraordinary dividend payable in a form other than stock, recapitalization, combination or reclassification, or a similar transaction
affecting the Company's outstanding securities without receipt of consideration, then (i) any new, substituted or additional securities
or other property (including money paid other than as an ordinary cash dividend) distributed with respect to any Restricted Stock
(or into which such Restricted Stock thereby become convertible) shall immediately be subject to the Repurchase Right; and (ii)
appropriate adjustments to reflect the distribution of such securities or property shall be made to the number and/or class of
the Restricted Stock and to the price per share to be paid upon the exercise of the Repurchase Right; provided, however, that the
aggregate purchase price payable for the Restricted Stock shall remain the same.

 

10.7 Successors and Assigns.
Except to the extent this Agreement is specifically limited by the terms and provisions of this Agreement, this Agreement shall
be binding upon and inure to the benefit of the parties hereto and their respective successor, assigns, heirs and personal representatives.

 

10.8 Governing Law. THIS
AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE, WITHOUT REGARD TO ITS CHOICE
OF LAW PROVISIONS, AS DELAWARE LAWS ARE APPLIED TO CONTRACTS ENTERED INTO AND PERFORMED IN SUCH STATE.

 

10.9 Severability. Should
any paragraph or any part of a paragraph within this Stock Purchase Agreement be rendered void, invalid or unenforceable by any
court of law for any reason, such invalidity or unenforceability shall not void or render invalid or unenforceable any other paragraph
or part of a paragraph in this Stock Purchase Agreement.

 

10.10 Attorneys' Fees.
In the event that any action, suit or proceeding is instituted upon any breach of this Agreement, the prevailing party shall be
paid by the other party thereto an amount equal to all of the prevailing party's costs and expenses, including attorneys' fees
incurred in each and every such action, suit or proceeding (including any and all appeals or petitions

    	39 

    	 

    

therefrom). As used in this Agreement, "attorneys'
fees" shall mean the full and actual cost of any legal services actually performed in connection with the matter involved
calculated on the basis of the usual fee charged by the attorney performing such services and shall not be limited to "reasonable
attorneys' fees" as defined in any statute or rule of court.

 

10.11 The Plan. This Agreement
is made pursuant to the Plan, and it is intended, and shall be interpreted in a manner, to comply herewith. Any provision of this
Agreement inconsistent with the Plan shall be superseded and governed by the Plan.

 

10.12 Miscellaneous. Title
and captions contained in this Agreement are inserted for convenience and reference only and do not constitute a part of this Agreement
for any purpose.

    	40 

    	 

    

SPOUSAL CONSENT

 

The undersigned spouse of __________________________
does hereby consent to the execution of the foregoing Agreement by _____________________, and the performance by him (or her) of
his (or her) obligations thereunder.

 

	Dated:_______________	 	 
	 	 	Signature

 

    	41 

    	 

    

EXHIBIT A

to

ANNEX I

of

STOCK PURCHASE AGREEMENT

 

PROMISSORY NOTE

 

 

	$	 	Date:

 

FOR VALUE RECEIVED, the undersigned promises
to pay to BIO LAB NATURALS, INC., a Delaware corporation, 201 Columbine St., 3rd Floor, Suite 11, Denver, CO 80206 (the "Company"),
the principal sum of $_______________ with interest from the date hereof on the unpaid principal balance at the rate of _______%
per annum, compounded annually. Accrued but unpaid interest under this Note shall be due and payable annually on the date immediately
preceding the anniversary of this Note, at the rate of ____% per annum, and the unpaid principal balance and any remaining accrued
but unpaid interest shall be due and payable on _______________, _____.

 

All sums paid hereunder shall be paid in lawful
money of the United States of America at the principal executive offices of the Company or at such other place as the holder of
this Note shall have designated to the undersigned in writing. The principal amount of this Note may be paid in whole or in part
(in either case with any interest accrued through the date of payment) at any time or from time to time, prior to maturity, without
penalty or charge for prepayment. All sums paid hereunder shall be applied first to any unpaid interest and then to the principal
amount then outstanding.

 

If service of the undersigned with the Company
is terminated for any reason, with or without cause, the holder of this Note shall be entitled at its option to demand payment
of the full principal amount of this Note then unpaid, together with all interest accrued thereon to the date of payment, by delivery
to the undersigned of written demand. Not later than 30 days after delivery of such demand the undersigned shall pay the principal
amount together with all accrued interest.

 

The undersigned shall pay to the holder of
this Note reasonable attorneys' fees and all costs and other expenses (including, without limitation, fees, costs and expenses
of litigation) incurred by the holder in enforcing this Note. This Note is secured by a Security Agreement of even date herewith
between the Company and the undersigned. The holder of this Note is entitled to the benefits of the Security Agreement and may
enforce the agreements of the undersigned contained therein and exercise the remedies provided for thereby or otherwise available
with respect to this Note.

 

 

Borrower:

 

 

Print name and Address:

 

    	42 

    	 

    

EXHIBIT B

to

ANNEX I

of

STOCK PURCHASE AGREEMENT

 

SECURITY AGREEMENT

 

 

THIS SECURITY AGREEMENT (the "Security
Agreement") is made and entered into as of the ___ day of ______________, ____, between BIO LAB NATURALS, INC., a Delaware
corporation ("Lender") and ___________________ ("Debtor").

 

WHEREAS, Debtor has concurrently herewith purchased
from Lender _____ shares of Lender's Stock (the "Stock") pursuant to that certain Stock Purchase Agreement, dated ________________,
____, between Lender and Debtor (the "Purchase Agreement") and has made payment therefor by delivery of Debtor's promissory
note of even date herewith (the "Note"); and

 

WHEREAS, Debtor and Lender desire to have Debtor
grant to Lender a security interest in the collateral described below as security for Debtor's performance of the terms and conditions
of the Purchase Agreement, the Note and this Security Agreement.

 

NOW, THEREFORE, on the basis of the above facts
and in consideration of the mutual covenants and agreements set forth below, Lender and Debtor agree as follows:

 

SECTION 1: GRANT OF SECURITY INTEREST.

 

As security for Debtor's full and faithful
performance of each and all of its obligations and liabilities under the Note, and any and all modifications, extensions or renewals
thereof, the Purchase Agreement and this Security Agreement, Debtor hereby grants and assigns to Lender a continuing security interest
in and to the Stock, and all stock dividends, cash dividends, liquidating dividends, new securities and all other property, moneys
and rights to which Debtor may become entitled on account thereof (the "Collateral").

 

SECTION 2: PERFECTION OF SECURITY INTEREST.

 

To perfect Lender's security interest in and
lien on the Collateral, Debtor shall, upon the execution of this Agreement, immediately deliver to Lender, together with collateral
instruments of transfer executed in blank, all certificates representing the Stock to be held by Lender until released pursuant
to Section 6 hereof.

 

SECTION 3: DEFAULT.

 

At the sole and exclusive option of Lender,
upon an Event of Default (as defined in Section 3.2 below) Lender may exercise any or all of the rights and remedies of a secured
party under the Delaware Uniform Commercial Code, as amended from time to time. All rights and remedies of Lender shall be cumulative
and may be exercised successively or concurrently and without impairment of Lender's interest in the Collateral.

 

 

    	43 

    	 

    

As used herein, an Event of Default ("Event
of Default") shall mean any of the following:

 

The failure of Debtor to perform any of its
obligations under the Purchase Agreement, the Note or this Security Agreement; or

 

The occurrence of one or more of the following:
(i) Debtor becoming the subject of any case or action or order for relief under the Bankruptcy Reform Act of 1978; (ii) the filing
by Debtor of a petition or answer to take advantage of any bankruptcy, reorganization, insolvency, readjustment of debts, dissolution
or liquidation law or statute, or the filing of any answer admitting the material allegations of a petition filed against Debtor
in any proceeding under any such law or the taking of any action by Debtor for the purpose of effecting the foregoing; the appointment
of a trustee, receiver or custodian of Debtor or any of Debtor's material assets or properties; (iii) Debtor making an assignment
for the benefit of creditors; or (iv) the occurrence of any other act by Debtor or Debtor's creditors which Lender reasonably determines
may jeopardize Debtor's ability to pay the Note or perform Debtor's obligations under the Purchase Agreement or this Security Agreement.

 

SECTION 4: WARRANTIES AND REPRESENTATIONS OF
DEBTOR.

 

Debtor hereby represents and warrants that
the Collateral is free and clear of any security interest, lien, restriction or encumbrance and that he has the full right and
power to transfer the Collateral to Lender free and clear thereof and to enter into and carry out the Purchase Agreement, the Note
and this Security Agreement.

 

SECTION 5: POWER OF ATTORNEY.

 

Debtor hereby appoints Lender's Secretary as
his true and lawful attorney-in-fact to transfer the Collateral or cause it to be transferred on Lender's books whenever Lender
determines in its sole and absolute discretion that such transfer is necessary or advisable to protect its rights or interests
under this Security Agreement.

 

SECTION 6: RELEASE OF THE COLLATERAL.

 

Within five days following receipt by Lender
of the unpaid principal amount of the Note from Debtor, Lender shall release from its security interest hereunder and deliver or
cause to be delivered to Debtor the Stock.

 

SECTION 7: WAIVERS.

 

No waiver by Lender of any breach or default
by Debtor under the Purchase Agreement, the Note or this Security Agreement shall be deemed a waiver of any breach or default thereafter
occurring, and the taking of any action by Lender shall not be deemed an election of that action in exclusion of any other action.
The rights, privileges, remedies and options granted to Lender under this Security Agreement or under any applicable law shall
be deemed cumulative and may be exercised successively or concurrently.

 

    	44 

    	 

    

SECTION 8: GENERAL PROVISIONS.

 

8.1 Notices. All notices,
requests, demands or other communications under this Security Agreement shall be in writing and shall be given to parties hereto
as follows: If to the Company, to:

 

BIO LAB NATURALS,
INC.

Attn: W. Edward Nichols, CEO

201 Columbine St., 3rd Floor, Suite 11

Denver, CO 80206

 

If to Debtor, to the address set forth in the
records of the Company, or such other address as may be furnished by either such party in writing to the other party hereto.

 

Any such notice, request, demand or other communication
shall be effective (i) if given by mail, 72 hours after such communication is deposited in the mail by first-class certified mail,
return receipt requested, postage prepaid, addressed as aforesaid, or (ii) if given by any other means, when delivered at the address
specified in this Paragraph 8.

 

8.2 Successors and Assigns.
This Security Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors, assigns,
heirs and personal representatives.

 

8.3 Severability. Should
any paragraph or any part of a paragraph within this Security Agreement be rendered void, invalid or unenforceable by any court
of law for any reason, such invalidity or unenforceability shall not void or render invalid or unenforceable any other paragraph
or part of a paragraph in this Security Agreement.

 

8.4 Governing Law. THIS
AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF DELAWARE WITHOUT REGARD TO ITS CHOICE
OF LAW PROVISIONS, AS DELAWARE LAWS ARE APPLIED TO CONTRACTS ENTERED INTO AND PERFORMED IN SUCH STATE.

 

8.5 Attorneys' Fees. In
the event that any action, suit or proceeding is instituted upon any breach of this Security Agreement, the prevailing party shall
be paid by the other party thereto an amount equal to all of the prevailing party's costs and expenses, including attorneys' fees
incurred in each and every such action, suit or proceeding (including any and all appeals or petitions therefrom). As used in this
Agreement, "Attorneys' Fees" shall mean the full and actual cost of any legal services actually performed in connection
with the matter involved calculated on the basis of the usual fee charged by the attorney performing such services and shall not
be limited to "reasonable attorneys' fees" as defined in any statute or rule of court.

 

8.6 Entire Agreement. The
making, execution and delivery of this Security Agreement by the parties hereto have been induced by no representations, statements,
warranties or agreements other than those herein expressed. This Security Agreement, the Purchase Agreement and the Note embody
the entire understanding of the parties and there are no further or other agreements or understandings, written or oral, in effect
between the parties relating to the subject matter hereof, unless expressly referred to by reference herein.

 

    	45 

    	 

    

8.7 Miscellaneous. Titles
and captions contained in this Security Agreement are inserted for convenience of reference only and do not constitute part of
this Security Agreement for any other purpose.

 

IN WITNESS WHEREOF, the parties hereto have
executed and delivered this Security Agreement as of the date first above written.

 

 

	DEBTOR:	 	LENDER: BIO LAB NATURALS, INC.
	 	 	By:
	(Sign)	 	W. Edward Nichols
	 	 	Its: CEO
	(Please print name and address)	 	 
	 	 	 
	 	 	 
	 	 	 

 

    	46 

    	 

    

 

EXHIBIT C

to

ANNEX I

of

STOCK PURCHASE AGREEMENT

 

STOCK ASSIGNMENT

SEPARATE FROM CERTIFICATE

 

 

For Value Received, _________________________________
("Holder") hereby sells, assigns and transfers unto ____________________________________ (________) shares (the "Shares")
of the Stock of BIO LAB NATURALS, INC., a Delaware corporation (the "Company"), held of record by Holder and represented
by Certificate No. ______, and hereby irrevocably constitutes and appoints as Holder's attorney to transfer the Shares on the books
of the Company, with full power of substitution in the premises.

 

The signature to this assignment must correspond
with the name written upon the face of the Certificate in every particular without any alteration or addition or any other change.

 

Dated

 

------------------------------

 

 

-------------------------------------------------------------------------------

(Signature of Holder)

 

-------------------------------------------------------------------------------

 

-------------------------------------------------------------------------------

(Please print name and address)

 

 

SIGNATURE GUARANTEED BY:

 

(Holder's signature must be guaranteed by a

bank, a trust company or a brokerage firm):

 

 

----------------------------------------------------

 

 

----------------------------------------------------

 

    	47 

    	 

    

LETTER REGARDING

FEDERAL AND _________ TAX CONSEQUENCES

 

BIO LAB NATURALS, INC.

201 Columbine St., 3rd Floor, Suite
11

Denver, CO 80206

 

 

[Purchaser]

 

 

Dear :

------------------------------

 

This letter is to notify you of certain federal
and ___________ income tax consequences to you as a result of your purchase of shares (the "Shares") of Common Stock
of BIO LAB NATURALS, INC. (the "Company") pursuant to the Stock Purchase Agreement dated __________, 20__ between you
and the Company.

 

The conclusion of this letter is that, if the
purchase price for the Shares equals their fair market value on the date you sign the Stock Purchase Agreement, you should send
copies of the attached form (the "Section 83 Form") relating to Section 83 ("Section 83") of the Internal Revenue
Code of 1986 (the "Internal Revenue Code"), to the Internal Revenue Service and the Company, not later than 30 days after
the date of the Stock Purchase Agreement. If the purchase price for the Shares is less than their fair market value on the date
you sign the Stock Purchase Agreement, you should consider carefully whether or not you should file the Section 83 Form within
30 days after you sign the Stock Purchase Agreement.

 

Federal Income Tax Consequences

 

Certain federal income tax consequences to
you in connection with your purchase of the Shares are determined in accordance with Section 83.

 

Section 83(a). Under Section 83(a), a person
to whom property is transferred in connection with the performance of services ("Section 83 property") must recognize
ordinary income in the year the property is transferred in an amount equal to the fair market value of the Section 83 property
at the time it is transferred less the amount, if any, paid for the Section 83 property, unless the Section 83 property is not
transferable and is subject to a substantial risk of forfeiture (collectively, a "Restriction on Transfer"). If there
is a Restriction on Transfer, then the person acquiring Section 83 property will not recognize income until the Restriction on
Transfer lapses (unless a Section 83(b) election is made - see below), at which time the person must recognize as ordinary income
the fair market value of the Section 83 property at that time less the amount, if any, paid for the Section 83 property.

 

    	48 

    	 

    

Your purchase of the Shares probably constitutes
a transfer of Section 83 property. Further, the Stock Purchase Agreement provides that, if you cease to be employed by the Company
for any reason, the Company must repurchase from you and you must sell to the Company all Non-Vested Shares (as defined in the
Stock Purchase Agreement) for an amount which may be less than their fair market value. Under Regulations promulgated under Section
83, these provisions probably constitute a Restriction on Transfer over your Non-Vested Shares. Thus, under Section 83(a), you
would not be required to recognize any income as a result of your purchase of the Shares until they vest; when they vest, you would
be required under Section 83(a) to recognize as ordinary income the excess, if any, of the fair market value of the Shares (as
of the day they vest) over the price you paid for those Shares under the Stock Purchase Agreement. If the price of the Company's
Common Stock is greater when the Shares vest than when you purchased them, you could have a substantial tax liability in connection
with your purchase of the Shares when they vest.

 

Section 83(b) Election. Section 83(b) provides
an alternative method for taxing Section 83 property. Under Section 83(b), a person may elect to recognize ordinary income in the
year Section 83 property is transferred to him or her, rather then waiting until it vests. Thus, if you make a Section 83(b) election,
you will be required to recognize as ordinary income in the year you purchase the Shares the difference, if any, between the fair
market value of the Shares on the date you sign the Stock Purchase Agreement and the purchase price you pay for the Shares. For
example, if you make the Section 83(b) election and you paid a purchase price for the Shares equal to their fair market value,
you will not pay any taxes in the year of the purchase in connection with your purchase of the Shares. On the other hand, if you
make the Section 83(b) election and the purchase price of the Shares is less than their fair market value on the date you sign
the Stock Purchase Agreement, you will be required to pay taxes on the difference between those amounts in the year of the purchase.
In either case, however, if you make the Section 83(b) election, you will not be required to recognize any income when the Shares
vest.

 

To make the Section 83(b) election, you must
file the Section 83 Form with both the Company and the Internal Revenue Service office where you file federal income tax returns.
You must file the Section 83(b) Form within 30 days after you sign the Stock Purchase Agreement. In addition, you must attach a
copy of the Section 83(b) Form to your income tax return that covers the year in which you filed the Form.

 

Sale of Section 83 Property. If a person sells
Section 83 property after the Restriction on Transfer lapses (or after making a Section 83(b) election), he or she will recognize
taxable gain or loss equal to the difference between the amount realized upon the sale of the Section 83 property and the person's
"adjusted basis" for the Section 83 property. The person's adjusted basis for the Section 83 property will be (i) the
amount paid for the Section 83 property plus (ii) any amount which the person has included in gross income pursuant to the Section
83(b) election. Thus, upon sale, you will recognize taxable gain or loss equal to the difference between the sale price of the
Shares and your adjusted basis for the Shares.

 

In general, the gain or loss you recognize
will be capital gain or loss if the following "Capital Gain Requirements" are met: (i) the Section 83 property is a capital
asset and (ii) the Section 83 property is held for more than 12 months from either the date the Restrictions on Transfer lapse
or, if a Section 83(b) election is made, the date the Section 83 property is acquired. Thus, as the Shares are probably a capital
asset in your hands, you will recognize capital gain or loss upon their sale if you hold them for more than 12 months from either
the date they vest or, if you make the Section 83(b) election, from the date you sign the Stock Purchase Agreement.

 

    	49 

    	 

    

Forfeiture of Section 83 Property. If a person's
interest in Section 83 property is forfeited, the person will recognize gain or loss equal to the difference between the amount
realized upon forfeiture and the amount paid for the Section 83 property. In your case, if your employment with the Company is
terminated before all of the Shares have vested, the Company is obligated to repurchase from you, and you are obligated to sell
to the Company, any Non-Vested Shares at the price you paid for them. As there would be no difference between the amount realized
upon forfeiture and the amount paid for the Shares, you would not be required to recognize any gain or loss at that time. However,
upon forfeiture, you would not be able to recoup any taxes you pay pursuant to a Section 83(b) election.

 

Delaware Income Tax Consequences.

 

The Delaware income tax consequences to you
in connection with your purchase of the Shares are identical to the federal income tax consequences. To make the Section 83(b)
election in Delaware, you must file the Section 83(b) Form with the Internal Revenue Service, as described above; there are no
extra filing requirements for making the Section 83(b) election in Delaware.

 

If you have any questions concerning the tax
consequences described in this letter, please feel free to call me.

 

Sincerely,

 

BIO LAB NATURALS, INC.

 

By: __________________________________________________

W. Edward Nichols

Its: CEO

    	50 

    	 

    

 

ELECTION TO INCLUDE IN GROSS INCOME IN

YEAR OF TRANSFER PURSUANT TO SECTION 83(b)

OF THE INTERNAL REVENUE CODE

 

 

The undersigned hereby makes an election pursuant
to the provisions of Section 83(b) of the Internal Revenue Code of 1986, as amended, and the regulations of the Commissioner of
Internal Revenue promulgated thereunder, with respect to the Section 83 property described below, and supplies the following information
in connection with that election:

 

The name, address, taxable year and taxpayer
identification number of the undersigned are:

 

	Name:	 	 
	 	 	 
	Address:	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	Taxable Year ________	 	Taxpayer I.D. No.__________

 

The description of the Section 83 property
with respect to which the undersigned is making the election is as follows:

 

_______________ (_____) shares (the "Subject
Shares") of the Common Stock of BIO LAB NATURALS, INC., a Delaware corporation (the "Company").

 

 

The date upon which the Subject Shares were
transferred to, and acquired by, the undersigned was ____________, ________.

 

The Subject Shares are subject to restrictions
under a ___________ vesting period. If the undersigned's employment terminates, the Company is obligated to purchase and the undersigned
is obligated to sell to the Company all Subject Shares that are not vested for a purchase price, which in certain circumstances
may be less than the fair market value of the Subject Shares.

 

The fair market value of the Subject Shares
at the time of the transfer to, and acquisition by, the undersigned (determined without regard to any restrictions other than restrictions
which by their terms will never lapse) was $_____ per share.

 

The amount paid by the undersigned for the
Subject Shares was $____ per share.

 

The undersigned has furnished a copy of this
election to the Company.

 

 

[Signature Page Follows]

    	51 

    	 

    

Dated:

---------------------------

 

 

 

 

 

------------------------------------------------------

(Signature)

 

Make 4 copies

 

(1) IRS (to be filed at the IRS where you ordinarily
file your returns) within 30 days of the purchase

(1) IRS (to be filed with your income tax return)

(1) BIO LAB NATURALS, INC.

(1) Copy for purchaser

 

 

 

    	52 

    	 

    

 

FORM OF RESOLUTIONS FOR PURCHASE RIGHTS GRANTS

 

 

RESOLUTIONS ADOPTED BY UNANIMOUS WRITTEN CONSENT

OF THE BOARD OF DIRECTORS OF

BIO LAB NATURALS, INC.

 

As of __________________, 20__

 

 

 

The undersigned directors, constituting the
entire board of directors (the "Board") of BIO LAB NATURALS, INC., a Delaware corporation (the "Company"),
hereby take the following actions, adopt the following resolutions, and transact the following business, by written consent without
a meeting, as of the date above written, pursuant to the applicable corporate laws of the State of Delaware and the Company's Bylaws.

 

WHEREAS, The Company Previously Adopted the
BIO LAB NATURALS, INC. STOCK OPTION AND AWARD INCENTIVE PLAN (The "Plan"), and has delegated the responsibility to administer
the Plan to the Board;

 

WHEREAS, Two Million (2,000,000) shares of
Common Stock of the Company were originally reserved for issuance under the Plan;

 

WHEREAS, as of the date hereof, _____________
shares remain available for issuance under the Plan; and

 

WHEREAS, the Board has determined that it is
in the best interests of this company and its stockholders to provide, under the plan, equity incentives to those employees of
the company identified below.

 

NOW, THEREFORE, BE IT RESOLVED, that the persons
listed on the Exhibit A, which exhibit was reviewed by the Board and shall be included with this Consent, are hereby granted, as
of the date hereof, the current right to purchase (the "Purchase Right") the number of shares at the per share purchase
price as set forth in Exhibit A at any time on or prior to the date which is 15 days from the date this grant is first communicated
to each recipient;

 

RESOLVED FURTHER, that this Company be, and
it hereby is, authorized to accept a promissory note from each purchaser as consideration for the stock so purchased, in such form
(including security for the obligation thereunder) heretofore approved by the Board;

 

RESOLVED FURTHER, that the officers of this
Company, and each of them, be, and they hereby are, authorized, directed and empowered for and on behalf of this Company to prepare
or cause to be prepared a stock purchase agreement, promissory note and/or security agreement (the "Purchase Agreements")
to represent the rights granted at this meeting substantially in the form, and containing the terms and provisions, heretofore
approved by the Board, and containing such other terms and provisions as such officers shall, upon advice of counsel, determine
to be necessary or appropriate, their execution of such Purchase Agreements to conclusively evidence such determination;

 

    	53 

    	 

    

RESOLVED FURTHER, that the Purchase Rights
shall be evidenced by stock purchase agreements and be subject to the restrictions (including transfer and/or repurchase rights),
if any, set forth in such stock purchase agreements;

 

RESOLVED FURTHER, that the Purchase Rights
shall be granted pursuant to the exemptions provided under Section 701 of the Securities Act Rules and Delaware Corporate Securities
Laws;

 

RESOLVED FURTHER, that there is hereby reserved
and set aside under the Plan the number of shares adequate to cover the shares underlying the Purchase Rights granted herein;

 

RESOLVED FURTHER, that upon receipt of executed
Purchase Agreements from the person or persons granted rights hereunder, the officers of this Company, and each of them, be, and
they hereby are, authorized, directed and empowered for and on behalf of this Company to issue the stock so purchased, and to do
or cause to be done all such further acts and things and to sign, deliver and/or file all such documents and notices as any of
such officers may deem necessary or advisable in order to carry out and perform the foregoing resolutions and the intention thereof;
and

 

RESOLVED FURTHER, that the officers of this
Company, and each of them, be, and they hereby are, authorized, directed and empowered for and on behalf of the Company to do or
cause to be done all such acts and things and to sign, deliver and/or file all such documents and notices as any of such officers
may deem necessary or advisable in order to carry out and perform the foregoing resolutions and the intention thereof.

 

The Secretary of the Corporation is directed
to file the original executed copy of this Consent with the minutes of proceedings of the Board.

 

IN WITNESS WHEREOF, each of the undersigned
has executed this consent as of the date first written above.

 

DIRECTORS:

 

	 	 	 
	W. Edward Nichols, Director	 	Darrell Avey, Director
	 	 	 
	 	 	 
	Jeremy Ostler, Director	 	Calvin D. Smiley, Sr., Director

 

 

 

 

 

    	54 

    	 

    

EXHIBIT A

 

 

Purchase Rights Grant Information

 

	Name	No. Shares	Purchase Price*
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

 

* The per share purchase price must be at least
85% of the Fair Market Value (as such term is defined in the Plan) of the underlying share as of the date of grant.

 

    	55EXHIBIT 10.1

 

AGREEMENT AND PLAN OF REORGANIZATION

 

This
Agreement and Plan of Reorganization ("Agreement") supercedes and replaces that Agreement of Merger between the
parties made and entered into as of December 31, 2019 (the "Effective Date"), by and among Prime Time Live, Inc.
, a Colorado corporation, with its principal office at 5770 S. Beech Court, Greenwood Village, Co. 80121 ("PTL"), and
Bio Lab Naturals, Inc., a Delaware Corporation with its principal office at 6764 S. Yates Ct. Littleton, Colorado (" BLAB"),
and PTL Acquisition Sub, Inc.., a wholly-owned subsidiary of BLAB, domiciled in Colorado
("Acquisition Sub"). Each of BLAB, PTL and Acquisition Sub
is referred to herein individually
as the "Parties."

RECITALS

 

A.                 
This reorganization, pursuant to which Acquisition Sub will acquire the assets and business
of PTL and PTL Acquisition Sub will survive, will produce the result of which the entire issued share capital of PTL (the "PTL
Shares") will be exchanged for and deemed for all purposes to represent
shares of common stock, par value $0.0001 per share, of BLAB upon the terms and subject to the conditions set forth in this Agreement.

 

B.                
The Parties intend that the Reorganization contemplated by this Agreement will qualify
as a tax-free reorganization within the meaning of Section 368 of the Internal Revenue Code of 1986, as amended, and the rules
and regulations promulgated thereunder (the "Tax Code").

 

NOW,
THEREFORE, in consideration of the foregoing and the representations, warranties and mutual covenants herein made, the parties
hereby agree to the foregoing and as follows:

 

Section
1. Definitions. Capitalized terms not otherwise defined herein have the meanings set forth in the attached Schedule 1.

 

Section 2. The Reorganization.

 

(a)                
Effecting the Reorganization. Upon the terms and subject to the conditions contained
in this Agreement, at the Effective Time (as hereinafter defined), (i) the assets of PTL shall be transferred to PTL Acquisition
Sub (the "Reorganization"); (ii) the separate corporate existence of PTL shall thereupon cease and PTL Acquisition
Sub will own the assets as the wholly-owned subsidiary of BLAB (sometimes referred to herein as the "Surviving Subsidiary"),
(iii) all the properties, rights and privileges, and power of PTL, shall vest in the PTL Acquisition Sub., and all debts, liabilities
and duties of PTL shall become the debts, liabilities and duties of PTL Acquisition Sub, and (iv) each share of common stock of
PTL issued and outstanding immediately prior to the Effective Time will be converted into and exchanged for one validly issued,
fully paid and non-assessable share of the Surviving Subsidiary's common stock.

 

		(b)	Effect on Capital Stock.

 

Conversion
of PTL Shares. At the Effective Time, each PTL Share issued and outstanding on
the Closing Date (as defined in Section 3, below) shall, by virtue of the Reorganization and without any action on the part of
PTL, BLAB, Acquisition Sub, or the holders of the PTL Shares as of the Closing Date (the "Original Holders"),
be converted into and will become one share of validly issued, fully paid and non-assessable common stock of BLAB (the "Share
Ratio") such that the Original Holders will be issued a total of five million five hundred thousand (5,500,000) common
shares of BLAB (the "BLAB Common Stock"), and such shares

    	1 

    	 

    

shall be distributed pro rata to the holders of
the PTL common stock subject to the receipt of Exchange Agreements with representations, in the form attached hereto as Schedule
1. All shares of BLAB Common Stock issued upon the exchange of PTL Shares in accordance with the terms hereof shall (i) contain
a restricted securities legend in compliance with the Securities Act and (ii) be deemed to have been issued in full satisfaction
of all rights pertaining to such PTL Shares. There shall be no further registration of transfers on the stock transfer books of
PTL of the PTL Shares that were outstanding immediately prior to the Effective Time.

 

Cancellation
of PTL Shares. At the Effective Time, the PTL Shares will be deemed canceled and retired and will cease to exist, and each
holder of a certificate for PTL Shares will cease to have any rights with respect thereto; provided, however, that, following
the Closing Date, upon surrender of an original stock certificate representing PTL Shares, BLAB will deliver a stock certificate
for shares of BLAB Common Stock to which such person is entitled pursuant to the Share Ratio, bearing any necessary or appropriate
restrictive legend. PTL shall thereafter be dissolved.

 

(c)                
Reorganization. The Parties intend to adopt this Agreement and the Reorganization as
a plan of reorganization under Section 368(a) of the Tax Code. The shares of BLAB Common Stock issued in the Reorganization will
be issued solely in exchange for PTL Shares, and no other transaction other than the Reorganization represents, provides for or
is intended to be an adjustment to the consideration paid for the PTL Shares. No consideration that could constitute "other
property" within the meaning of Section 356(b) of the Tax Code is being transferred by BLAB for PTL Shares in the Reorganization.
The parties shall not take a position on any tax return inconsistent with this Section 2(c).

 

(d)               
Further Actions. If at any time after the Effective Time, BLAB or PTL reasonably determines
that any deeds, assignments, or instruments, or conformations of transfer are necessary or desirable to carry out the purposes
of this Agreement, the officers and directors of BLAB and PTL are fully authorized in the name of their respective corporations
or otherwise to take, and will take, all such lawful and necessary or desirable actions.

 

(e)                
Options: There are Options for common shares of PTL outstanding, which shall be assumed
in the transaction, by BLAB for conversion to Common stock (Schedule 4).

 

(f)       Lock-up
Shares. The shares of BLAB Common Stock issued to the PTL Inside Shareholders (as defined below) shall be locked up for twelve
(12) months after the Closing Date pursuant to the terms of the lock-up agreement which shall be substantially in the form of Exhibit
A attached hereto ("Lock-Up Agreement"). "PTL Inside Shareholders" shall be defined as PTL's officers,
directors, employees, affiliates (ten percent (10%) shareholders, and any affiliates of each of those parties. The company may
release portions of any such shares from the lockup in accordance with any Form 1-A or Registration under the '33 Act. filed for
portions of the insider shares.

    	2 

    	 

    

		(g)	Registration Rights.

 

(i)                
BLAB shall file a Form 1-A within 60 days after closing, for the common shares of BLAB, including
any shares convertible from Preferred stock to common stock and pursue such filing to effectiveness, subject to adverse material
events in the business of Prime Time Live, and adverse market conditions. BLAB shall have the right to terminate or withdraw any
registration initiated by it for PTL stock under this Section 2(g) before the effective date of such registration, in the event
of adverse market conditions, or due to material changes in the business of Prime Time Live, Inc.

 

(ii)              
All expenses (other than underwriting discounts and commissions and stock transfer taxes and
fees) incurred in connection with a registration pursuant to Section 2(g) including, without limitation, registration, filing and
qualification fees, printers' and accounting fees, audit fees, and legal fees and costs of securities counsel for BLAB shall be
borne by BLAB, post-reorganization. (Such fees are NOT included in any compensation shares to any party.)

 

(iv)       The
covenants contained herein above shall survive the closing and shall be enforceable by an action by shareholders for injunction,
or damages, whether or not contained a separate agreement.

 

Section 3. Closing.

 

(i)                 
Closing Date. On the terms and subject to the conditions of this Agreement, the closing
of the Reorganization (the "Closing") shall be deemed effective on December 31, 2019, even if closed in escrow
so that some of the conditions can be subsequently met and any document deliveries may be made using the Effective date of Dec.
31, 2019, regardless of the actual date of delivery. All document deliveries must
be made on or before Feb. 15, 2020, or this agreement shall expire. (the "Closing Date").

 

G)         
Documents to be Delivered by BLAB. On or before the Closing, BLAB will deliver or cause
to be delivered to PTL:

(i)  
all consents or approvals required to be obtained by BLAB for the purposes of completing the
Plan of Reorganization;

 

(ii)               
a certified copy of a resolution of the directors of BLAB dated as of the Closing Date appointing
specified new Officers, designated by PTL, which shall include one person-full or part time-who is qualified to act as CFO for
the purposes of keeping all accounting records in accordance with SEC Rules and regulations for audits on a current basis;

 

(iii)   
certified copies of such resolutions of the directors of BLAB as are required to be passed
to authorize the execution, delivery and implementation of this Agreement;

 

Section
4. Current Directors and Officers of BLAB. The Officers of BLAB shall resign effective upon the appointment of the new Officers,
designated by PTL. The Current Director of BLAB shall remain as the sole director until the completion of a reorganization with
a NASDAQ qualified company, within six months from the date hereof. Should a reorganization with a NASDAQ qualified company not
be accomplished within six months from the closing hereof, then the Board of BLAB may take whatever actions it deems appropriate
and in the interest of shareholders at such time,

    	3 

    	 

    

including appointing additional
directors, of the Board's choice. Officers shall be appointed by subsequent minutes, as deemed appropriate.

 

Section
5. PTL's Representations and Warranties. PTL represents and warrants to BLAB that the statements contained in this Section
are true and correct as of the Effective Date and will be true and correct as of the Closing Date, as set forth herein and in the
disclosure schedule delivered by PTL to BLAB (the " PTL Schedule"), arranged in sections corresponding to the
paragraphs in this Section; the disclosure in any section or paragraph will qualify
other paragraphs in this Section to the extent that it is reasonably apparent from a reading of the disclosure that it also qualifies
or applies to such other paragraphs.

 

(a)  
Organization. PTL is a corporation validly existing and in good standing under the
laws of the State of Colorado and has all requisite power and authority and possesses all necessary governmental approvals necessary
to own, lease and operate its properties, to carry on its business as now being conducted, to execute and deliver this Agreement
and the agreements contemplated herein, and to consummate the transactions contemplated hereby and thereby. PTL is duly qualified
to do business and is in good standing in all jurisdictions in which its ownership of property or the character of its business
requires such qualification, except where the failure to be so qualified would not reasonably be expected to have an Adverse Effect.
Certified copies of the Certificate of Incorporation of PTL, as amended to date, each as currently in effect, have been made available
to BLAB, are complete and correct, and no amendments have been made thereto or have been authorized since the date thereof. PTL
is not in violation of any of the provisions of its Certificate of Incorporation or Bylaws.

		(b)	Capitalization.

 

(i) 
PTL's authorized capital consists solely of 100,000,000 PTL common Shares, and 5,700,000 Common
shares are outstanding as of date hereof).

 

(ii) 
There are 5,700,000 PTL common shares outstanding and no other authorized or issued PTL Common
Shares or other measure of capital ownership of PTL, except stock options under the current plan for employees. There are no agreements,
arrangements or understandings to which PTL is a party (written or oral) to issue any other PTL Shares or other measures of capital
ownership of PTL. All of the outstanding PTL Shares were duly and validly issued and fully paid, are non-assessable and free of
preemptive rights, and were issued in compliance with all applicable state and federal securities laws.

 

		(iii)	Except as provided in the PTL Schedule (Schedule 4), there are no outstanding

(A)
options, warrants, or other rights to purchase from PTL any PTL Shares or other measures of capital ownership of PTL; (B) debt
securities or instruments convertible into or exchangeable for PTL Shares or other measures of capital ownership of PTL; or (C)
commitments of any kind for the issuance of additional PTL Shares or options, warrants or other securities of PTL.

 

There
are no options or other rights to acquire such Shares or other measures of capital ownership and there are no preemptive rights
or agreements, arrangements or understandings to issue preemptive rights with respect to the issuance or sale of any PTL Shares
or other measures of capital ownership of PTL created by statute, the Certificate of Incorporation or Bylaws, or any agreement
or other arrangement to which PTL is a party or to which it is bound and there are no agreements, arrangements or understandings
to which PTL is a party (written or

    	4 

    	 

    

 

 

 

oral) pursuant
to which PTL has the right to elect to satisfy any liability by issuing any PTL Shares or other measures of capital ownership of
PTL.

(v)
Other than the Bylaws, PTL is not a party or subject to any agreement or understanding, and, to PTL's knowledge, there is no agreement,
arrangement or understanding between or among any persons which affects, restricts or relates to voting, giving of written consents,
distributions, allocation of profits and losses, or transferability of Shares or other measures of capital ownership of PTL, including
any voting trust agreement or proxy.

 

(c)               
Authorization. PTL has all requisite power and authority to execute and deliver this
Agreement, to perform its obligations hereunder, and to consummate the transactions contemplated hereby. The execution and delivery
of this Agreement by PTL and the consummation by PTL of the transactions contemplated hereby have been duly and validly authorized
by all necessary corporate and/or stockholder action by PTL and no other corporate proceedings on the part of PTL and no other
stockholder vote or consent is necessary to authorize this Agreement or to consummate the transactions contemplated hereby. This
Agreement has been duly and validly executed and delivered by PTL. This Agreement and all other agreements and obligations entered
into and undertaken in connection with the transactions contemplated hereby to which PTL is a party constitute the valid and legally
binding obligations of PTL, enforceable against PTL in accordance with their respective terms, except as may be limited by principles
of equity or applicable bankruptcy, reorganization, insolvency, moratorium, fraudulent conveyance or other similar laws relating
to or affecting the rights and remedies of creditors generally. The execution, delivery and performance by PTL of this Agreement
and the agreements provided for herein, and the consummation by PTL of the transactions contemplated
hereby and thereby, will not, with or without the giving of notice or the passage of time or both, violate the provisions of the
Certificate of Incorporation or Bylaws of PTL, or (i) violate any judgment, decree, order or award of any court, governmental body
or arbitrator; (ii) conflict with or result in the breach or termination of any term
or provision of, or constitute a default under, or cause any acceleration under, or cause the creation of any lien, charge or encumbrance
upon the properties or assets of PTL pursuant to, any indenture, mortgage, deed of trust or
other instrument or agreement to which PTL is a party or by which PTL or any of its properties is or may be bound; or (iii)
to PTL's Knowledge, violate the provisions of any law, rule or regulation applicable to PTL, except where such violation would
not reasonably be expected to have an Adverse Effect.

(d)               
No Conflict. The execution and delivery of this Agreement by PTL does not require any
consent or approval under, result in any breach of, result in any loss of any benefit under, or constitute a change of control
or default (or an event which with notice or lapse of time or both would become a default) under; give to others any right of termination,
vesting, amendment, acceleration or cancellation of; or result in the creation of any lien or encumbrance on any property or asset
of PTL pursuant to; any material agreement of PTL or other instrument or obligation of PTL.

 

(e)                
Litigation. There is no action, suit, legal or administrative proceeding or investigation
pending or, to PTL's Knowledge, threatened against or involving PTL (either as a plaintiff or defendant) before any court or governmental
agency, authority, body or arbitrator. There is not in existence on the date hereof any order, judgment or decree of any court,
tribunal or agency to PTL's Knowledge enjoining or requiring PTL to take any action of any kind with respect to its business, assets
or properties.

    	5 

    	 

    

(f)                   
Insurance. The PTL Schedule contains a listing of all current PTL insurance policies.
To PTL's Knowledge, all current insurance policies are in full force and effect, are in amounts of a nature that are adequate and
customary for PTL's business, and to PTL's Knowledge are sufficient for compliance with all legal requirements and agreements to
which it is a party or by which it is bound. All premiums due on current policies or renewals have been paid, and there is no material
default under any of the policies.

(g)               
Personal Property. PTL has good and marketable title to all of its tangible personal
property free and clear of all liens, leases, encumbrances, claims under bailment and storage agreements, equities, conditional
sales contracts, security interests, charges, and restrictions, except for liens, if any, for personal property taxes not due.
Such property is used by PTL in the ordinary course of its business and is sufficient for continued conduct of PTL's business after
the Closing Date in substantially the same manner as conducted prior to the Closing Date. Such property is in good operating condition
and repair, normal wear and tear excepted, and normal maintenance has been performed.

(h)               
Intangible Property. PTL owns, or possesses, adequate licenses or other valid rights
to use all existing United States and foreign patents, trade names, service marks, copyrights, trade secrets, and applications
therefor listed in the PTL Schedule, which are material to its business as currently conducted (the "PTL Intellectual Property
Rights"), except where the failure to have such PTL Intellectual Property Rights would not reasonably be expected to have
an Adverse Effect. PTL has the right and authority to use, and to continue to use such PTL

(i)                 
Intellectual Property Rights after the Closing Date, such property in connection with the
conduct of its business in the manner presently conducted, and to its Knowledge such use or continuing use does not and will not
materially infringe upon or violate any rights of any other person, subject to the outcome of the PTL Litigation.

 

(j)                 
Real Property. Except as specified on the PTL Schedule, PTL is not a party to any material
lease agreements and does not have any interests in any parcel of real property, improved or otherwise.

(k)               
Tax Matters. Within the times and in the manner prescribed by law, PTL has filed, or
will have filed, all federal, state and local tax returns and all tax returns for other governing bodies having jurisdiction to
levy taxes upon it that are required to be filed. PTL has paid all taxes, interest, penalties, assessments and deficiencies that
have become due, including without limitation income, franchise, real estate, and sales and withholding taxes. No examinations
of the federal, state or local tax returns of PTL are currently in progress or threatened and no deficiencies have been asserted
or to PTL's Knowledge assessed against PTL as a result of any audit by the Internal Revenue Service or any state or local taxing
authority and no such deficiency has been proposed or threatened.

(1)
Books and Records, and Audit. The general ledger and books of account of PTL, all minute books of PTL, all federal, state
and local income, franchise, property and other tax returns filed by PTL, all of which have been made available to BLAB, are in
all material respects complete and correct and have been maintained in accordance with good business practice and in accordance
with all applicable procedures required by laws and regulations, except as would reasonably be expected to have an Adverse Effect.
The financial statements of PTL shall be audited by Ben F. Borgers, CPAs in accordance
with GAAP, and all SEC rules and regulations, so

    	6 

    	 

    

as
to promptly afford BLAB the opportunity to file its Offering Statement or Registration Statement under the Securities Act of 1933.
PTL shall pay such charges.

(m)     
Contracts and Commitments. The PTL Schedule lists all material contracts and agreements
to which PTL is a party, whether written or oral, other than those between PTL and BLAB. Each such contract is a valid and binding
agreement of PTL, enforceable against PTL in accordance with its terms, is in full force and effect and represents the material
terms of the agreement between the respective parties. PTL has materially complied with all obligations required pursuant to such
contracts to have been performed by PTL on its part and neither PTL nor, to PTL's Knowledge, any other party to such contract is
in breach of or default in any material respect under any such contract.

(n)               
Compliance with Laws. PTL has all requisite licenses, permits and certificates, including
environmental, health and safety permits, from federal, state and local authorities necessary to conduct its business as currently
conducted and own and operate its assets, except where the failure to have such permits would not reasonably be expected to have
an Adverse Effect. To PTL's Knowledge, PTL is not in violation of any federal, state or local law, regulation or ordinance (including,
without limitation, laws, regulations or ordinances relating to building, zoning, environmental, disposal of hazardous waste, land
use or similar matters) relating to its business or its properties.

(o)                
Employee Benefit Plans. Except as specified on the PTL Schedule, PTL has no (A) employee
benefit plans as defined in ERISA Section 3(3), (B) bonus, stock option, stock purchase, incentive, deferred compensation, supplemental
retirement, severance or other similar employee benefit plans, or (C) material unexpired
severance agreements with any current or former employee.

(p)               
Indebtedness to and from Affiliates. PTL
is not indebted, directly or to PTL's Knowledge indirectly, to any officer, director or affiliate (10%) stockholder of PTL in any
amount other than for salaries for services rendered or reimbursable business expenses, and no such person is indebted to PTL except
for advances made to employees of PTL in the ordinary course of business to meet reimbursable business expenses.

(q)                
Regulatory Approvals. All consents, approvals,
authorizations or other requirements prescribed by any law, rule or regulation that must be obtained or satisfied by PTL and that
are necessary for the execution and delivery by PTL of this Agreement or any documents to be executed and delivered by PTL in connection
therewith have been, or prior to the Closing Date will be, obtained and satisfied.

(r)                 
No Brokers. No broker or finder has acted for PTL in connection with this Agreement
or the transactions contemplated hereby, and no broker or finder is entitled to any brokerage or finder's fee or other commissions
in respect of such transactions based upon agreements, arrangements, or understandings made by or on behalf of PTL.

(s)                
Disclosure. The information concerning PTL set forth in this Agreement, the exhibits
and schedules hereto, and any document, statement or certificate furnished or to be furnished in connection herewith does not and
will not contain any untrue statement of a material fact or omit to state a material fact required to be stated herein or therein
or necessary to make the

    	7 

    	 

    

statements and facts
contained herein or therein, in light of the circumstances in which they are made, not false or misleading.

(t)                 
Tax Treatment. Neither PTL nor, to the Knowledge of PTL, any of its Affiliates has
taken or agreed to take action that would prevent the Reorganization from constituting a reorganization qualifying under the provisions
of Section 368 of the Tax Code.

 

(u)                
Absence of Liabilities. Except as set forth on PTL's balance sheet PTL does not have
any liability or obligation, secured or unsecured, whether accrued, absolute, contingent, unasserted or otherwise, that exceeds
an aggregate of $1,000.

Section
6. BLAB's, Acquisition Sub's Representations and Warranties. Each of BLAB, and Acquisition Sub represents and warrants to PTL,
the surviving corporation, that the statements contained in this Section are true and correct as of the Effective Date and will
be true and correct as of the Closing Date, as set forth herein and in the disclosure schedule delivered by Acquisition Sub to
PTL (the "BLAB Schedule"), arranged in sections corresponding to the paragraphs in this Section to the extent
that it is reasonably apparent from a reading of the disclosure that it also qualifies or applies to such other paragraphs.

 

		(a)	Organization.

 

(i)                   
BLAB is a corporation validly existing and in good standing under the laws of the State of
Delaware and has all requisite power and authority and possesses all necessary governmental approvals necessary to own, lease and
operate its properties, to carry on its business as now being conducted, to execute
and deliver this Agreement and the agreements contemplated herein, and to consummate the transactions contemplated hereby and thereby.
BLAB is duly qualified to do business and is in good standing in all jurisdictions in which its ownership of property or the character
of its business requires such qualification, except where the failure to be so qualified would not reasonably be expected to have
an Adverse Effect. Certified copies of its Articles of Incorporation and Bylaws, as amended to date, have been made available to
PTL, are complete and correct, and no amendments have been made thereto or have been authorized since the date thereof. BLAB is
not in violation of any of the provisions of its Articles of Incorporation or Bylaws.

 

(ii)         
Acquisition Sub is a corporation validly existing and in good standing under the laws of the
State of Colorado and has all requisite power and authority and possesses all necessary governmental approvals necessary to own,
lease and operate its properties, to carry on its business as now being conducted, to execute and deliver this Agreement and the
agreements contemplated herein, and to consummate the transactions contemplated hereby and thereby. Certified copies of its Certificate
of Incorporation and Bylaws have been made available to PTL, are complete and correct, and no amendments have been made thereto
or have been authorized since the date thereof. Acquisition Sub is not in violation of any of the provisions of its Certificate
of Incorporation or Bylaws.

		(b)	Capitalization.

(i)                  
Acquisition Sub. PTL Acquisition Corp. has 1,000 shares authorized and 1,000 shares issued
and outstanding to BLAB.

    	8 

    	 

    

(ii)               
BLAB's authorized capital stock consists of 1,000,000,000 shares of common stock, and 9,308,566
shares of Common Stock are issued and outstanding and 10,000,000 shares of Preferred stock are authorized There will be, at closing,
three million (3,000,000) common shares (approximately) of common stock issued and outstanding of BLAB, and 500,000 shares of Series
A Super Majority Voting Preferred Convertible Stock issued and outstanding to Ed Nichols and M. A. Littman equally, or if no reorganization
is completed, then such will be cancelled, and 2,000 Series AA Preferred Shares are held in treasury for cancellation and approximately
6,556,539 shares of common stock of BLAB are deemed held by BLAB for cancellation pursuant to a Rescission Agreement, and such
shares will be cancelled prior to closing hereunder. All of the issued and outstanding shares of common stock of BLAB were duly
and validly issued and fully paid, are non-assessable and free of preemptive rights, and were issued in compliance with all applicable
state and federal securities laws.

(iii)        
Except as shown on the Schedule 6.(b) iii attached hereto, there are no outstanding (A) options,
warrants, or other rights to purchase from BLAB any capital stock of BLAB or Acquisition Sub; (B) debt securities or instruments
convertible into or exchangeable for shares of such stock; or (C) commitments of any kind for the issuance of additional shares
of capital stock or options, warrants or other securities of BLAB or Acquisition Sub.

(iv)               
BLAB owns all of the outstanding capital stock of Acquisition Sub, 1,000 shares, free and
clear of all liens or other encumbrances.

(c)               
No Subsidiaries. Except for Acquisition Sub and as provided in the BLAB Schedule, BLAB
does not own any capital stock or other equity interest in any corporation, partnership, joint venture or other entity.

(d)               
Authorization. Each of BLAB and Acquisition Sub has all requisite power and authority
to execute and deliver this Agreement, to perform its obligations hereunder and to consummate the transactions contemplated hereby.
The execution and delivery of this Agreement by BLAB and Acquisition Sub and the consummation by BLAB and Acquisition Sub of the
transactions contemplated hereby have been duly and validly authorized by all necessary corporate action by BLAB or Acquisition
Sub, respectively, and no other corporate proceedings on the part of BLAB or Acquisition Sub, respectively, and no stockholder
vote or consent is necessary to authorize this Agreement or to consummate the transactions contemplated hereby. This Agreement
has been duly and validly executed and delivered by BLAB and Acquisition Sub. This Agreement and all other agreements and obligations
entered into and undertaken in connection with the transactions contemplated hereby to which BLAB or Acquisition Sub is a party
constitute the valid and legally binding obligations of BLAB and Acquisition Sub, respectively, enforceable against BLAB and Acquisition
Sub, respectively, in accordance with their terms, except as may be limited by principles of equity or applicable bankruptcy, reorganization,
insolvency, moratorium, fraudulent conveyance or other similar laws relating to or affecting the rights and remedies of creditors
generally. The execution, delivery and performance by BLAB and Acquisition Sub of this Agreement and the agreements provided for
herein, and the consummation by BLAB and Acquisition Sub of the transactions contemplated hereby and thereby, will not, with or
without the giving of notice or the passage of time or both, violate the provisions of the Articles of Incorporation or Bylaws
of BLAB, the Certificate of Incorporation or Bylaws of Acquisition Sub, or (i) violate any judgment, decree, order or award of
any court, governmental body or arbitrator;

 

		(ii)	conflict with or result in the breach or termination
of any term or provision of, or constitute a default under, or cause any acceleration under, or cause the creation of any lien,
charge or encumbrance upon the properties or assets of BLAB or Acquisition Sub pursuant to, any

    	9 

    	 

    

indenture, mortgage,
deed of trust or other instrument or agreement to which BLAB or Acquisition Sub is a party or by which BLAB Acquisition Sub or
any of their respective properties is or may be bound; or (iii) to BLAB's or Acquisition Sub's 's Knowledge, violate the provisions
of any law, rule or regulation applicable to BLAB or Acquisition Sub, except where such violation would not reasonably be expected
to have an Adverse Effect.

(e)               
No Conflict. The execution and delivery of s Agreement by BLAB or Acquisition Sub does
not require any consent or approval under, result in any breach of, any loss of any benefit under or constitute a change of control
or default (or an event which with notice or lapse of time or both would become a default) under, or give to others any right of
termination, vesting, amendment, acceleration or cancellation of, or result in the creation of any lien or encumbrance on any property
or asset of BLAB or Acquisition Sub pursuant to any material agreement of BLAB or Acquisition Sub or other instrument or obligation
of BLAB or Acquisition Sub.

 

(f)                
Absence of Liabilities. Acquisition Sub does not have any liability or obligation,
secured or unsecured, whether accrued, absolute, contingent, unasserted or otherwise, that exceeds an aggregate of $1,000. BLAB
owes a total of $25,000 plus accrued interest to Kyle Isreal, for payment made to the prior Transfer agent, which shall be converted
to common stock of PTL at

$.1250 per share concurrent with the closing and exchanged
for BLAB shares thereupon..

 

(g)               
Tax Treatment. Neither BLAB nor, to the Knowledge of BLAB, any of its Affiliates has
taken or agreed to take action that would prevent the Reorganization from constituting a reorganization qualifying under the provisions
of Section 368 of the Tax Code.

Section 7.
Other Covenants and Agreements of the Parties.

 

(a)                  
Acquisition Sub Consent of Stockholders. Acquisition Sub shall take all action necessary,
in accordance with the Business Corporation Act of the State of Colorado, and its Certificate of Incorporation and Bylaws, to
obtain the unanimous written consent of its stockholders as practicable. to approve the adoption and approval of this Agreement
and the transactions contemplated hereby.

 

(b)         
PTL Shareholders Approval. PTL shall take all action necessary, in accordance with
the Corporation Law of the State of Colorado, and its Certificate of Incorporation and Bylaws, to obtain written consent of at
least 51% of its shareholders, in lieu of a shareholder meeting to approve the adoption and approval of this Agreement and the
transactions contemplated hereby.

 

(c)                         
BLAB Compensation Arrangements. BLAB intends to enter into certain compensation arrangements
with consultants of PTL concurrent with closing for services (2,000,000 Series B Preferred Convertible shares--convertible to
common stock upon the completion of a reorganization with a target company,, within 6 months from the date hereof, otherwise redeemable
for $50,000), as set forth on Schedule 2.

 

(d)          
Expenses. Simultaneous with the execution PTL will pay a deposit for the expenses
shown on Schedule 3, which shall be expended only for the purposes set forth.

Section
8. PTL's Conditions to the Reorganization. The obligation of PTL to effect the Reorganization shall be subject to the fulfillment
at or prior to the Closing Date of the following conditions, unless waived by PTL:

    	10 

    	 

    

(a)     
Each of the representations and warranties of BLAB and Acquisition Sub contained in this Agreement
shall be true and correct as of the date of this Agreement, except to the extent that
any changed circumstances, or events making such representations and warranties not true or correct would not, individually or
in the aggregate, constitute an Adverse Effect and at the Closing each of BLAB and Acquisition Sub shall have delivered to PTL
a certificate to that effect;

 

(b)   
Any governmental or third-party approvals required to effect the Reorganization shall have
been obtained;

 

(c)   
Each of BLAB and Acquisition Sub shall have performed or complied in all material respects
with all agreements and covenants required by this Agreement to be performed or complied with by it on or prior to the Effective
Time and at the Closing BLAB shall have delivered to PTL a certificate to that effect;

 

(d)   
From the date of this Agreement through the Effective Time, there shall not have occurred
any change, circumstance or event concerning BLAB or Acquisition Sub that has had or could be reasonably likely to have an Adverse
Affect;

 

(e)     
PTL shall have received a resolution from BLAB's Board of Directors,
approving the Reorganization and authorizing the issuances of the shares of BLAB Common Stock hereto, and appointing the
new directors, concurrent with the resignation of the prior directors.

 

(f)    
The stockholder of Acquisition Sub (BLAB) and the stockholders of PTL shall have approved
the principal terms of this Agreement, the Reorganization and the transactions contemplated herein in accordance with applicable
law and their Certificate of Incorporation and Bylaws.

 

(g)   
BLAB shall have changed its name to a name to be chosen by the Board to be effective upon
approval by FINRA.

 

(h)    
BLAB shall promptly, after closing, apply to the OTCQB, for listing in accordance with its
rules and it shall obtain OTC approval as soon as possible after closing.

 

(i)      
BLAB shall file with FINRA for the approval of a name change and a new symbol, concurrent
with closing, to be made effective as soon as possible.

 

Section
9. BLAB's, Acquisition Sub's Conditions to the Reorganization. The obligations of BLAB and Acquisition Sub to effect the Reorganization
shall be subject to the fulfillment at or prior to the Closing Date of the following conditions, unless waived by BLAB:

(a)                
Each of the representations and warranties of PTL contained in this Agreement shall be true
and correct as of the date of this Agreement, except to the extent that any changes, circumstances or events making such representations
and warranties not true or correct would not, individually or in the aggregate, constitute an Adverse Effect and at the Closing
PTL shall have delivered to BLAB a certificate to that effect;

    	11 

    	 

    

(b)                  
PTL shall have performed or complied in all material respects with all agreements and covenants
required by this Agreement to be performed or complied with by it on or prior to the Effective Time and at the Closing PTL shall
have delivered to BLAB a certificate to that effect;

 

(c)                
From the date of this Agreement through the Effective Time, there shall not have occurred
any change, circumstance, or event concerning PTL that has had or could be reasonably likely to have an Adverse Affect;

(d)                      
PTL shall have delivered to BLAB a complete and accurate PTL shareholder Schedule and such
schedule shall have been approved by BLAB;

(e)
                    PTL shall have delivered to BLAB audited balance sheets of PTL as of Dec 31, 2019, and the related statements of operations,
changes in shareholders' equity and cash flows and footnotes from inception, in compliance with SEC rules and regulations,
and GAAP.

(f)            
At closing, PTL shall have delivered to BLAB an executed copy of the Lock-Up Agreement, duly
executed by BLAB and each of the exchanging PTL shareholders who own ten per cent (10%) or more of the common stock of BLAB, post
reorganization, except with the permission of the company in conjunction with the filing of a Registration Statement under the
'33 Act, or a Form 1-A which may include a portion of the shares of the insiders.

 

Section
10. Indemnification of Directors and Officers. All rights to indemnification by PTL and BLAB existing in favor of each individual
who is an officer or director of PTL or BLAB of the date of this Agreement (each such individual, an "Indemnified Person")
for his acts and omissions as a director or officer of PTL or BLAB occurring prior to the Effective Time, as provided in PTL's
Certificate of Incorporation or Bylaws (as in effect as of the date of this Agreement) or BLAB's Articles of Incorporation or
Bylaws (as in effect as of the date of this Agreement) shall survive the Reorganization
and shall continue in full force and effect (to the fullest extent such rights to indemnification are available under and are
consistent with applicable law) for a period of six years from the Closing Date.

 

Section
11. Confidentiality. Each Party shall ensure that any nonpublic information provided to it by any other Party in confidence
shall be treated as strictly confidential and that all such confidential information that each Party or any of its respective
officers, directors, employees, attorneys, agents, investment bankers, or accountants may now possess or may hereinafter create
or obtain relating to the financial condition, results of operations, businesses, properties, assets, liabilities, or future prospects
of the other such parties, any affiliate thereof, or any customer or supplier thereof shall not be published, disclosed, or made
accessible by any of them to any other person at any time or used by any of them, in each case without the prior written consent
of the other Party; provided, however, that the restrictions of this Section shall not apply (a) as may otherwise be required
by law, (b) as may be necessary or appropriate in connection with the enforcement of this Agreement, or (c) to the extent such
information was in the public domain when received or thereafter enters the public domain other than because of disclosures by
the receiving Party. Each such Party shall cause all of such other persons who received confidential information, from time to
time to deliver to the disclosing party all tangible evidence of such confidential information to which the restrictions of this
Section apply upon written request.

 

    	12 

    	 

    

 

Section
12. Termination

 

(a)          
This Agreement may be terminated and abandoned at any time prior to the Effective
Time of the Reorganization:

 

 

	 	i.	by mutual written
                          consent of BLAB and PTL;
	 	 	 
		ii.	by either BLAB or PTL if any governmental entity
shall have issued an order, decree or ruling or taken any other action permanently enjoining, restraining or otherwise prohibiting
the Reorganization and such order, decree, ruling or other action shall have become final and nonappealable;

 

		iii.	by either BLAB or PTL, so long as such Party
is not in breach hereunder, if the Reorganization shall not have been consummated on or before closing date (other than as a result
of the failure of the party seeking to terminate this Agreement to perform its obligations
under this Agreement required to be performed at, or prior to, the Effective Time of the Reorganization, in which event such party
may not terminate this Agreement pursuant to this provision for a period of ten days following such party's cure of such failure);
provided, however, that if either BLAB or PTL requests an extension of the Closing after this date and the other Party consents
in writing, then neither Party may terminate this Agreement under this provision until the expiration of such extension period;
	 	 	 
	 	iv.	by
BLAB, if there has been a material breach of this Agreement on the part of PTL of its obligations hereunder or if any of its representations
or warranties contained herein shall be materially inaccurate and such breach or inaccuracy is not curable or, if curable, is
not cured within ten (10) days after written notice of such breach is given by BLAB to PTL; or

	 	 	 
	 	v.	by PTL, if there has
                                                                                       been a material breach of this Agreement on the part of BLAB of its obligations hereunder or if any of its representations or
                                                                                       warranties contained herein shall be materially inaccurate and such breach or inaccuracy is not curable or, if curable,
                                                                                       is not cured within ten (10) days after written notice of such breach is given by PTL to BLAB.

  

(b)             
In the event of termination of this Agreement by either PTL or BLAB provided in this Section
12, this Agreement shall forthwith become void and have no effect, without any
liability or obligation on the part of BLAB or PTL, other than the provisions of the last sentence of Section 11 and this
Section 12. Nothing contained in this Section 12 shall relieve any Party for any breach of the representations,
warranties, covenants or agreements set forth in this Agreement.

 

Section 13. Miscellaneous.

 

(a)                
Survival. The representations and warranties of the Parties will terminate at the Effective
Time and only those covenants that by their terms survive the Effective Time shall survive the Effective Time. This Section 13
shall survive the Effective Time.

 

(b)             
Press Releases and Public Announcements. No Party will issue any press release or make
any public announcement relating to the subject matter of this Agreement without the prior

    	13 

    	 

    

written
approval of the other Parties; provided, however, that any Party may make any public disclosure it believes in good faith
is required by applicable law or any listing requirement or trading agreement.

 

(c)                
No Third-Party Beneficiaries. This Agreement will not confer any rights or remedies
upon any person other than the Parties and their respective successors and permitted assigns.

 

(d)               
Notices. All notices
required or permitted under this Agreement will be in writing and will be given by certified or regular mail or by any other reasonable
means (including personal delivery, facsimile, or reputable express courier) to the Party to receive notice at the following addresses
or at such other address as any Party may, by notice, direct:

To BLAB & Acquisition Sub: Bio Lab Naturals,
Inc. PTL Acquistion Sub, Inc..

  

To PTL: Prime Time Live, Inc.

 

With a copy to: (which will
not constitute notice):

 

Michael A. Littman

Attorney at Law

PO Box 1839

Arvada, CO 80001

 

All
notices given by certified mail will be deemed as given on the delivery date shown on the return mail receipt, and all notices
given in any other manner will be deemed as given when received.

(e)                
Waiver. The rights and remedies of the Parties to this Agreement are cumulative and
not alternative. Neither the failure nor any delay by any Party in exercising any right, power, or privilege under this Agreement
or the documents referred to in this Agreement will operate as a waiver of such right, power, or privilege, and no single or partial
exercise of any right, power, or privilege will preclude any other or further exercise of such right, power, or privilege or the
exercise of any other right, power, or privilege. To the maximum extent permitted by applicable law, (a) no claim or right arising
from this Agreement or the documents referred to in this Agreement can be discharged by one Party, in whole or in part, by a waiver
or renunciation of the claim or right unless in writing signed by the waiving Party, (b) no waiver that may be given by a Party
will be applicable except in the specific instance for which it is given, and (c) no notice to or demand on one Party will be deemed
to be a waiver of any obligation of such Party or of the right of the Party giving such notice or demand to take further action
without notice or demand as provided in this Agreement or the documents referred to in this Agreement.

(f)                
Further Assurances.
The Parties agree (a) to furnish upon request to each other such further information, (b) to execute and deliver to each other
such other documents, and (c) to do such other acts and things, all as the other Parties
may reasonably request for the purpose of carrying out the intent of this Agreement and of the documents referred to in this Agreement.

 

(g)                
Successors and Assigns. This Agreement will be binding upon and inure to the benefit
of the Parties and their respective successors and permitted assigns. No Party may assign

    	14 

    	 

    

either
this Agreement or any of its rights, interests, or obligations hereunder without the prior written approval of the other Parties,
which may be granted or withheld at the sole discretion of such other Parties. Any unauthorized assignment is void.

 

(h)                
Severability. Any provision of this Agreement that is invalid, illegal or unenforceable
in any jurisdiction will, as to that jurisdiction, be ineffective to the extent of such invalidity, illegality or unenforceability,
without affecting in any way the remaining provisions hereof in such jurisdiction or rendering that or any other provision of this
Agreement invalid, illegal or unenforceable in any other jurisdiction.

 

(i)                 
Expenses. Each Party will pay all fees and expenses (including, without limitation,
legal and accounting fees and expenses) incurred by such Party in connection with the transactions contemplated by this Agreement.

G)
Governing Law. This Agreement will
be governed by and construed in accordance with the laws of the State of Colorado, without giving effect to principles of conflicts
of laws.

 

(k)             
Counterparts: Signatures. This Agreement may be executed in one or more counterparts,
each of which will be deemed to be an original, but all of which will be one and the same document. Facsimiles and electronic copies
in portable document format ("PDF") containing original signatures shall be deemed for all purposes to be originally
signed copies of the documents that are the subject of such facsimiles or PDF versions.

(1)               
Entire Agreement. This Agreement, the schedules and exhibits hereto, and the agreements
and instruments to be delivered by the Parties on Closing represent the entire understanding and agreement between the Parties
and supersede all prior oral and written and all contemporaneous oral negotiations, commitments and understandings.

 

(m)
Amendment. This Agreement may be amended by the Parties hereto by action taken by or on behalf of their respective Boards
of Directors at any time prior to the Effective Time. This Agreement may not be amended by the Parties hereto except by execution
of an instrument in writing signed on behalf of each of BLAB, PTL, and Acquisition Sub.

[Signature page to followJ

    	15 

    	 

    

IN WITNESS WHEREOF, the
parties hereto have executed this Agreement and Plan of Reorganization as of the date first above written.

PRIME TIME LIVE, INC.

 

 

		By:	/s/ Darrell Avey
	 	Its:	Chief Executive Officer

 

 

 

 

PTL ACQUISITION Sub, Inc.

 

		By:	W. Edward Nichols
	 	Its:	Chief Executive Officer

 

 

 

BIO LAB NATURALS, INC.

		By:	W. Edward Nichols
	 	Its:	President

 

 

    	16 

    	 

    

 

 

Schedule
1-Exchange Agreement with Representations Schedule 2 Form of Series B Preferred Stock

Schedule 3-Expenses to be Paid

 

$10,000 for the DTC approval
cost. (Delete this as we will have new Nasdaq company pay). If we decide to apply earlier we will incur the cost.

 

$ 7,500 for OTCPink application

 

Transfer Agent fees related
to reorganization and cancellations -Estimated at $3,000 Recording fees for name change-approx-$500

Recording fees for Series
A and B stock approx. $500 FINRA filing fee $500 for name and symbol change

Schedule 4-PTL Options and Warrants

 

 

 

Schedule 6 b (iii)

 

		a)	Shares previously awarded for services in
July- August of 2019, approximately 375,000 common shares and 25,000 for additional services thereafter.
	 	 	 

		b)	Shares for conversion of a $25,000 note of
Kyle Isreal-200,000 common shares

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00311-of-00352.parquet"}]]